source
stringlengths 2
222
| date
stringlengths 19
19
| url
stringlengths 22
853
⌀ | text
stringlengths 0
10k
⌀ | title
stringlengths 0
701
| context_id
stringlengths 1
9
| document_id
stringclasses 2
values | document_type
stringclasses 2
values |
|---|---|---|---|---|---|---|---|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2019-12-05 12:30:00
| null |
XPRESSPA ANNOUNCES RENEWED PARTNERSHIP AND SUCCESSFUL MEDIATION OF LONG-STANDING DISPUTE AT HARTSFIELD-JACKSON ATLANTA INTERNATIONAL AIRPORT.XPRESSPA GROUP INC - XPRESSPA HAS AGREED TO RESUME ITS JOINT VENTURE WITH CORDIAL ENDEAVOR CONCESSIONS OF ATLANTA.XPRESSPA GROUP INC - FAA IS IN AGREEMENT WITH SETTLEMENT AGREEMENT, AND PARTIES INVOLVED WILL SEEK DISMISSAL OF ALL PENDING LITIGATION.
|
XPRESSPA SAYS CO HAS AGREED TO RESUME ITS JOINT VENTURE WITH CORDIAL ENDEAVOR CONCESSIONS OF ATLANTA
|
XSPA
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2019-11-14 21:30:00
| null |
XPRESSPA ANNOUNCES THIRD QUARTER 2019 FINANCIAL RESULTS.XPRESSPA GROUP INC QTRLY TOTAL REVENUES WAS $12.5 MILLION IN 2019 COMPARED TO $12.9 MILLION IN PRIOR YEAR.XPRESSPA GROUP INC - QTRLY TOTAL REVENUE $12.5 MILLION VERSUS $12.9 MILLION.XPRESSPA GROUP INC QTRLY LOSS PER SHARE $1.68.
|
XPRESSPA ANNOUNCES THIRD QUARTER 2019 FINANCIAL RESULTS
|
XSPA
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2019-11-13 22:30:00
| null |
XPRESSPA GROUP, INC. ANNOUNCED EARNINGS RESULTS FOR THE THIRD QUARTER ENDED SEPTEMBER 30, 2019. FOR THE THIRD QUARTER, THE COMPANY ANNOUNCED TOTAL REVENUE WAS USD 12.531 MILLION COMPARED TO USD 12.922 MILLION A YEAR AGO. OPERATING LOSS WAS USD 1.836 MILLION COMPARED TO USD 2.885 MILLION A YEAR AGO. NET LOSS WAS USD 4.844 MILLION COMPARED TO USD 3.187 MILLION A YEAR AGO. BASIC LOSS PER SHARE WAS USD 1.68 COMPARED TO USD 2.25 A YEAR AGO. FOR THE NINE MONTHS, TOTAL REVENUE WAS USD 37.669 MILLION COMPARED TO USD 38.560 MILLION A YEAR AGO. OPERATING LOSS WAS USD 5.803 MILLION COMPARED TO USD 29.009 MILLION A YEAR AGO. NET LOSS WAS USD 14.155 MILLION COMPARED TO USD 30.643 MILLION A YEAR AGO. BASIC LOSS PER SHARE WAS USD 6.33 COMPARED TO USD 22.48 A YEAR AGO. BASIC LOSS PER SHARE FROM CONTINUING OPERATIONS WAS USD 6.33 COMPARED TO USD 21.66 A YEAR AGO.
|
XPRESSPA GROUP, INC. REPORTS EARNINGS RESULTS FOR THE THIRD QUARTER ENDED SEPTEMBER 30, 2019
|
XSPA
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2019-11-10 22:30:00
| null |
XPRESSPA GROUP, INC., Q3 2019 EARNINGS CALL, NOV 14, 2019
|
XPRESSPA GROUP, INC., Q3 2019 EARNINGS CALL, NOV 14, 2019
|
XSPA
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2019-10-29 22:30:00
| null |
XPRESSPA GROUP, INC. ANNOUNCED THAT THE COMPANY HAS SIGNED A STRATEGIC PARTNERSHIP WITH PERSONA. XPRESSPA WILL OFFER PERSONA’S PRODUCTS IN ALL OF ITS DOMESTIC AIRPORT LOCATIONS WITH STAFF TRAINED ON THE PRODUCTS BY PERSONA’S NUTRITIONISTS. CUSTOMERS WILL BE ABLE TO PURCHASE THREE DIFFERENT NUTRITION PACKS DESIGNED ESPECIALLY FOR TRAVELERS TO SUPPORT RELAXATION, IMMUNITY OR JET LAG, WITH CUSTOMERS RECEIVING AN EXCLUSIVE DISCOUNT ON THEIR FIRST ORDER. XPRESSPA EXPECTS TO LAUNCH PERSONA IN ITS AIRPORT LOCATIONS BY THE END OF 2019.
|
XPRESSPA GROUP, INC. ANNOUNCES STRATEGIC PARTNERSHIP WITH PERSONA
|
XSPA
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2019-10-20 22:30:00
| null |
XPRESSPA GROUP, INC. ANNOUNCED THE RELOCATION OF THE COMPANY’S GLOBAL SUPPORT CENTER IN NEW YORK CITY FROM 780 THIRD AVENUE IN MIDTOWN MANHATTAN TO 254 W 31ST STREET, ACROSS FROM PENN STATION. THE NEW XPRESSPA GLOBAL SUPPORT CENTER WILL HOUSE ALL CORPORATE EMPLOYEES AND WILL YIELD AN ANNUAL COST REDUCTION OF $0.3 MILLION IN OCCUPANCY EXPENSES.
|
XPRESSPA GROUP, INC. ANNOUNCES RELOCATION OF GLOBAL SUPPORT CENTER TO 254 W 31ST STREET
|
XSPA
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2023-07-07 06:00:00
| null |
HANGZHOU, CHINA , JULY 7, 2023 /PRNEWSWIRE/ -- YUNJI INC. ("YUNJI" OR THE "COMPANY") (NASDAQ: YJ), A LEADING MEMBERSHIP-BASED SOCIAL E-COMMERCE PLATFORM, TODAY ANNOUNCED THAT IT RECEIVED A NOTIFICATION LETTER (THE "COMPLIANCE NOTICE") FROM THE LISTING QUALIFICATIONS DEPARTMENT OF THE NASDAQ STOCK MARKET INC. ("NASDAQ") DATED JULY 5, 2023, INDICATING THAT THE COMPANY HAS REGAINED COMPLIANCE WITH THE NASDAQ LISTING RULE 5450(A)(1) (THE "MINIMUM BID PRICE REQUIREMENT") AND THE MATTER IS CLOSED. ON JANUARY 11, 2023, YUNJI RECEIVED A NOTIFICATION LETTER (THE "DEFICIENCY NOTICE") FROM THE NASDAQ INDICATING THAT THE CLOSING BID PRICE FOR THE COMPANY'S AMERICAN DEPOSITARY SHARES ("ADSS") WAS BELOW THE MINIMUM BID PRICE OF $1.00 REQUIRED FOR CONTINUED LISTING UNDER NASDAQ LISTING RULE 5450(A)(1) FOR 30 CONSECUTIVE BUSINESS DAYS.
|
YUNJI HAS REGAINED COMPLIANCE WITH NASDAQ'S MINIMUM BID PRICE REQUIREMENT
|
YJ
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2023-06-02 06:00:00
| null |
HANGZHOU, CHINA , JUNE 2, 2023 /PRNEWSWIRE/ -- YUNJI INC. ("YUNJI" OR THE "COMPANY") (NASDAQ: YJ), A LEADING MEMBERSHIP-BASED SOCIAL E-COMMERCE PLATFORM, TODAY ANNOUNCED ITS UNAUDITED FINANCIAL RESULTS FOR THE FIRST QUARTER ENDED MARCH 31, 2023 [1]. FIRST QUARTER 2023 HIGHLIGHTS TOTAL REVENUES IN THE FIRST QUARTER OF 2023 WERE RMB178.7 MILLION (US$26.0 MILLION), COMPARED WITH RMB342.6 MILLION IN THE SAME PERIOD OF 2022.
|
YUNJI ANNOUNCES FIRST QUARTER 2023 UNAUDITED FINANCIAL RESULTS
|
YJ
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2023-04-26 08:30:00
| null |
HANGZHOU, CHINA , APRIL 26, 2023 /PRNEWSWIRE/ -- YUNJI INC. ("YUNJI" OR THE "COMPANY") (NASDAQ: YJ), A LEADING MEMBERSHIP-BASED SOCIAL E-COMMERCE PLATFORM, TODAY ANNOUNCED THAT IT HAS FILED ITS ANNUAL REPORT ON FORM 20-F FOR THE FISCAL YEAR ENDED DECEMBER 31, 2022 WITH THE SECURITIES AND EXCHANGE COMMISSION ON APRIL 26, 2023 EASTERN TIME. THE ANNUAL REPORT CAN BE ACCESSED ON THE COMPANY'S INVESTOR RELATIONS WEBSITE AT HTTPS://INVESTOR.YUNJIGLOBAL.COM.
|
YUNJI FILES 2022 ANNUAL REPORT ON FORM 20-F
|
YJ
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2023-03-20 06:00:00
| null |
HANGZHOU, CHINA , MARCH 20, 2023 /PRNEWSWIRE/ -- YUNJI INC. ("YUNJI" OR THE "COMPANY") (NASDAQ: YJ), A LEADING MEMBERSHIP-BASED SOCIAL E-COMMERCE PLATFORM, TODAY ANNOUNCED ITS UNAUDITED FINANCIAL RESULTS FOR THE FOURTH QUARTER AND FISCAL YEAR ENDED DECEMBER 31, 2022 [1]. FOURTH QUARTER 2022 HIGHLIGHTS TOTAL REVENUES IN THE FOURTH QUARTER OF 2022 WERE RMB288.7 MILLION (US$41.9 MILLION), COMPARED WITH RMB471.4 MILLION IN THE SAME PERIOD OF 2021.
|
YUNJI ANNOUNCES FOURTH QUARTER AND FISCAL YEAR 2022 UNAUDITED FINANCIAL RESULTS
|
YJ
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2023-01-05 06:00:00
| null |
HANGZHOU, CHINA , JAN. 5, 2023 /PRNEWSWIRE/ -- YUNJI INC. ("YUNJI" OR THE "COMPANY") (NASDAQ: YJ), A LEADING MEMBERSHIP-BASED SOCIAL E-COMMERCE PLATFORM, TODAY ANNOUNCED THAT THE FINAL LARGE-SCALE PROMOTIONAL EVENT BEFORE THE LUNAR NEW YEAR, THE NEW YEAR FESTIVE GOODS SHOPPING FESTIVAL ("THE EVENT"), SUCCESSFULLY CONCLUDED AT THE END OF DECEMBER 2022. THE EVENT SHOWCASED AND PROMOTED YUNJI'S FLAGSHIP PRODUCTS ACROSS A WIDE VARIETY OF DIFFERENT CATEGORIES.
|
YUNJI SUCCESSFULLY CONCLUDES ITS NEW YEAR FESTIVE GOODS SHOPPING FESTIVAL
|
YJ
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2022-11-29 06:00:00
| null |
HANGZHOU, CHINA , NOV. 29, 2022 /PRNEWSWIRE/ -- YUNJI INC. ("YUNJI" OR THE "COMPANY") (NASDAQ: YJ), A LEADING MEMBERSHIP-BASED SOCIAL E-COMMERCE PLATFORM, TODAY ANNOUNCED ITS UNAUDITED FINANCIAL RESULTS FOR THE THIRD QUARTER ENDED SEPTEMBER 30, 2022 [1]. THIRD QUARTER 2022 HIGHLIGHTS TOTAL REVENUES IN THE THIRD QUARTER OF 2022 WERE RMB238.9 MILLION (US$33.6 MILLION), COMPARED WITH RMB437.9 MILLION IN THE SAME PERIOD OF 2021.
|
YUNJI ANNOUNCES THIRD QUARTER 2022 UNAUDITED FINANCIAL RESULTS
|
YJ
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2022-08-25 06:00:00
| null |
HANGZHOU, CHINA , AUG. 25, 2022 /PRNEWSWIRE/ -- YUNJI INC. ("YUNJI" OR THE "COMPANY") (NASDAQ: YJ), A LEADING MEMBERSHIP-BASED SOCIAL E-COMMERCE PLATFORM, TODAY ANNOUNCED ITS UNAUDITED FINANCIAL RESULTS FOR THE SECOND QUARTER ENDED JUNE 30, 2022 1. SECOND QUARTER 2022 HIGHLIGHTS TOTAL REVENUES IN THE SECOND QUARTER OF 2022 WERE RMB284.0 MILLION (US$42.4 MILLION), COMPARED WITH RMB570.7 MILLION IN THE SAME PERIOD OF 2021, PRIMARILY DUE TO THE NEGATIVE IMPACT OF THE OUTBREAKS OF THE HIGHLY-TRANSMISSIBLE DELTA AND OMICRON VARIANTS OF COVID-19 IN THE FIRST HALF OF 2022 ON THE COMPANY'S OPERATIONS AND THE COMPANY'S CONTINUED STRATEGY TO REFINE ITS PRODUCT SELECTION ACROSS ALL CATEGORIES AND OPTIMIZE ITS SELECTION OF SUPPLIERS AND MERCHANTS, CAUSING NEAR-TERM DECREASES IN SALES.
|
YUNJI ANNOUNCES SECOND QUARTER 2022 UNAUDITED FINANCIAL RESULTS
|
YJ
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2022-08-01 09:00:00
| null |
HANGZHOU, CHINA , AUG. 1, 2022 /PRNEWSWIRE/ -- YUNJI INC. ("YUNJI" OR THE "COMPANY") (NASDAQ: YJ), A LEADING MEMBERSHIP-BASED SOCIAL E-COMMERCE PLATFORM, TODAY ANNOUNCED THE CELEBRATION OF ITS PRIVATE-LABEL SKIN CARE BRAND SUYE'S 12TH ANNIVERSARY. SUYE GENERATED OVER 21 MILLION RMB SALES OF ITS HIGH-QUALITY PRODUCTS DURING ITS ANNIVERSARY MONTH OF JULY, INCLUDING ITS NEWLY LAUNCHED GHK-CU (COPPER GLYCYL-HISTIDINE-TRIPEPTIDE) MULTI-EFFECT REPAIRING FREEZE DRIED SET AND POLYPEPTIDE ANTI-WRINKLE KIT.
|
YUNJI'S TECHNOLOGY-EMPOWERED PRIVATE LABEL SUYE CELEBRATES ITS 12TH ANNIVERSARY
|
YJ
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2022-06-28 07:00:00
| null |
HANGZHOU, CHINA , JUNE 28, 2022 /PRNEWSWIRE/ -- YUNJI INC. ("YUNJI" OR THE "COMPANY") (NASDAQ: YJ), A LEADING MEMBERSHIP-BASED SOCIAL E-COMMERCE PLATFORM, TODAY ANNOUNCED THAT THE COMPANY'S ONGOING DEVELOPMENT OF INNOVATIVE TECHNOLOGY IS YIELDING POSITIVE RESULTS. THE RECENTLY-LAUNCHED SECOND GENERATION OF YUNJI'S MEGAHIT PRODUCT, FRUIT AND VEGETABLE PRESSED CANDY FROM ITS PRIVATE LABEL QINGZIYANG, REACHED THE MILESTONE OF FIVE MILLION SALES WITHIN ONE MINUTE AND TEN MILLION SALES WITHIN TWENTY MINUTES DURING ITS LAUNCH DAY ON JUNE 14, 2022.
|
YUNJI EMPOWERS ITS PRIVATE LABEL BRAND QINGZIYANG WITH ADVANCED TECHNOLOGY
|
YJ
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2022-05-31 06:00:00
| null |
HANGZHOU, CHINA , MAY 31, 2022 /PRNEWSWIRE/ -- YUNJI INC. ("YUNJI" OR THE "COMPANY") (NASDAQ: YJ), A LEADING MEMBERSHIP-BASED SOCIAL E-COMMERCE PLATFORM, TODAY ANNOUNCED ITS UNAUDITED FINANCIAL RESULTS FOR THE FIRST QUARTER ENDED MARCH 31, 2022 [1]. FIRST QUARTER 2022 HIGHLIGHTS TOTAL REVENUES IN THE FIRST QUARTER OF 2022 WERE RMB342.6 MILLION (US$54.0 MILLION), COMPARED WITH RMB675.4 MILLION IN THE SAME PERIOD OF 2021, PRIMARILY DUE TO THE NEGATIVE IMPACT OF THE OUTBREAKS OF THE HIGHLY-TRANSMISSIBLE DELTA AND OMICRON VARIANTS OF COVID-19 IN EARLY 2022 ON THE COMPANY'S OPERATIONS AND THE COMPANY'S CONTINUED STRATEGY TO REFINE ITS PRODUCT SELECTION ACROSS ALL CATEGORIES AND OPTIMIZE ITS SELECTION OF SUPPLIERS AND MERCHANTS, CAUSING NEAR-TERM DECREASES IN SALES.
|
YUNJI ANNOUNCES FIRST QUARTER 2022 UNAUDITED FINANCIAL RESULTS
|
YJ
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2022-05-19 07:00:00
| null |
HANGZHOU, CHINA , MAY 19, 2022 /PRNEWSWIRE/ -- YUNJI INC. ("YUNJI" OR THE "COMPANY") (NASDAQ: YJ), A LEADING MEMBERSHIP-BASED SOCIAL E-COMMERCE PLATFORM, IS CELEBRATING ITS SEVENTH ANNIVERSARY THIS MONTH. DURING ITS SEVENTH YEAR IN BUSINESS, YUNJI FURTHER UPDATED THE PRODUCT CURATION STRATEGY IT HAS ADHERED TO SINCE ITS ESTABLISHMENT.
|
YUNJI MARKS SEVEN-YEAR ANNIVERSARY WITH PRODUCT CURATION STRATEGY UPGRADE
|
YJ
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2022-05-05 06:00:00
| null |
HANGZHOU, CHINA , MAY 5, 2022 /PRNEWSWIRE/ -- YUNJI INC. ("YUNJI" OR THE "COMPANY") (NASDAQ: YJ), A LEADING MEMBERSHIP-BASED SOCIAL E-COMMERCE PLATFORM, TODAY PROVIDES AN UPDATE ON ITS STATUS UNDER THE HOLDING FOREIGN COMPANIES ACCOUNTABLE ACT (THE "HFCAA"). THE COMPANY HAS BEEN PROVISIONALLY IDENTIFIED BY THE UNITED STATES SECURITIES AND EXCHANGE COMMISSION (THE "SEC") UNDER THE HFCAA AS A COMMISSION-IDENTIFIED ISSUER ON MAY 4, 2022.
|
YUNJI PROVIDES UPDATE ON STATUS UNDER HOLDING FOREIGN COMPANIES ACCOUNTABLE ACT
|
YJ
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2022-05-01 05:00:00
| null |
HANGZHOU, CHINA , MAY 1, 2022 /PRNEWSWIRE/ -- YUNJI INC. ("YUNJI" OR THE "COMPANY") (NASDAQ: YJ), A LEADING MEMBERSHIP-BASED SOCIAL E-COMMERCE PLATFORM, TODAY ANNOUNCED THAT MR. CHENGQI ZHANG HAS RESIGNED AS VICE PRESIDENT OF FINANCE OF THE COMPANY FOR PERSONAL REASONS, EFFECTIVE MAY 6, 2022.
|
YUNJI ANNOUNCES CHANGES TO MANAGEMENT
|
YJ
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2022-04-26 09:15:00
| null |
HANGZHOU, CHINA , APRIL 26, 2022 /PRNEWSWIRE/ -- YUNJI INC. ("YUNJI" OR THE "COMPANY") (NASDAQ: YJ), A LEADING MEMBERSHIP-BASED SOCIAL E-COMMERCE PLATFORM, TODAY ANNOUNCED THAT IT HAS FILED ITS ANNUAL REPORT ON FORM 20-F FOR THE FISCAL YEAR ENDED DECEMBER 31, 2021 WITH THE SECURITIES AND EXCHANGE COMMISSION ON APRIL 26, 2022 EASTERN TIME. THE ANNUAL REPORT CAN BE ACCESSED ON THE COMPANY'S INVESTOR RELATIONS WEBSITE AT HTTPS://INVESTOR.YUNJIGLOBAL.COM.
|
YUNJI FILES 2021 ANNUAL REPORT ON FORM 20-F
|
YJ
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2022-03-24 07:00:00
| null |
HANGZHOU, CHINA, MARCH 24, 2022 /PRNEWSWIRE/ -- YUNJI INC. ("YUNJI" OR THE "COMPANY") (NASDAQ: YJ), A LEADING MEMBERSHIP-BASED SOCIAL E-COMMERCE PLATFORM, TODAY ANNOUNCED THAT IT RECEIVED A NOTIFICATION LETTER (THE "COMPLIANCE NOTICE") FROM THE LISTING QUALIFICATIONS DEPARTMENT OF THE NASDAQ STOCK MARKET INC. ("NASDAQ") DATED MARCH 23, 2022, INDICATING THAT THE COMPANY HAS REGAINED COMPLIANCE WITH THE NASDAQ LISTING RULE 5450(A)(1) (THE "MINIMUM BID PRICE REQUIREMENT") AND THE MATTER IS CLOSED. ON SEPTEMBER 27, 2021, YUNJI RECEIVED A NOTIFICATION LETTER (THE "DEFICIENCY NOTICE") FROM THE NASDAQ INDICATING THAT THE CLOSING BID PRICE FOR THE COMPANY'S AMERICAN DEPOSITARY SHARES ("ADSS") WAS BELOW THE MINIMUM BID PRICE OF $1.00 REQUIRED FOR CONTINUED LISTING UNDER NASDAQ LISTING RULE 5450(A)(1) FOR 30 CONSECUTIVE BUSINESS DAYS.
|
YUNJI HAS REGAINED COMPLIANCE WITH NASDAQ'S MINIMUM BID PRICE REQUIREMENT
|
YJ
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2022-03-17 05:10:00
| null |
HANGZHOU, CHINA, MARCH 17, 2022 /PRNEWSWIRE/ -- YUNJI INC. ("YUNJI" OR THE "COMPANY") (NASDAQ: YJ), A LEADING MEMBERSHIP-BASED SOCIAL E-COMMERCE PLATFORM, TODAY ANNOUNCED ITS UNAUDITED FINANCIAL RESULTS FOR THE FOURTH QUARTER AND FISCAL YEAR ENDED DECEMBER 31, 2021 [1] AND THE AUTHORIZATION BY ITS BOARD OF DIRECTORS OF A US$20 MILLION SHARE REPURCHASE PROGRAM. FOURTH QUARTER 2021 HIGHLIGHTS TOTAL REVENUES IN THE FOURTH QUARTER OF 2021 WERE RMB471.4 MILLION (US$74.0 MILLION), COMPARED WITH RMB1,327.4 MILLION IN THE SAME PERIOD OF 2020, PRIMARILY DUE TO THE COMPANY'S STRATEGY TO REFINE ITS PRODUCT SELECTION ACROSS ALL CATEGORIES AND CAREFULLY CURATE PRODUCTS TO IMPLEMENT ITS MEGAHIT PRODUCT POOL INITIATIVE FOCUSING ON THE DEVELOPMENT OF PRIVATE LABELS AND EXCLUSIVE PRODUCTS.
|
YUNJI ANNOUNCES FOURTH QUARTER AND FISCAL YEAR 2021 UNAUDITED FINANCIAL RESULTS AND US$20 MILLION SHARE REPURCHASE PROGRAM
|
YJ
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2022-02-22 06:00:00
| null |
HANGZHOU, CHINA, FEB. 22, 2022 /PRNEWSWIRE/ -- YUNJI INC. ("YUNJI" OR THE "COMPANY") (NASDAQ: YJ), A LEADING MEMBERSHIP-BASED SOCIAL E-COMMERCE PLATFORM, TODAY ANNOUNCED THE LAUNCH OF A PREMIUM PRODUCT LINE UNDER ITS PRIVATE LABEL BRAND, SOLO LIFE. WITH AN 11-YEAR TRACK RECORD AND BILLIONS IN ANNUAL SALES, SOLO LIFE'S NEW PREMIUM PRODUCT LINE PROVIDES CUSTOMERS WITH HIGHER-QUALITY PROFESSIONAL-LEVEL PRODUCTS, BRINGING CUSTOMERS PEACE OF MIND IN TERMS OF SAFETY AND EFFICACY.
|
YUNJI ANNOUNCES THE LAUNCH OF A PREMIUM PRODUCT LINE BY ITS PRIVATE LABEL BRAND SOLO LIFE
|
YJ
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2022-01-28 09:00:00
| null |
HANGZHOU, CHINA, JAN. 28, 2022 /PRNEWSWIRE/ -- YUNJI INC. ("YUNJI" OR THE "COMPANY") (NASDAQ: YJ), A LEADING MEMBERSHIP-BASED SOCIAL E-COMMERCE PLATFORM, ANNOUNCED THAT IT WILL CONTINUE TO PROVIDE ITS E-COMMERCE SERVICE TO ITS PLATFORM MEMBERS DURING THE CHINA MINISTRY OF COMMERCE'S 2022 ONLINE LUNAR NEW YEAR SHOPPING FESTIVAL EVENT ("THE EVENT") AND RELATED HOLIDAY SHOPPING CAMPAIGNS. YUNJI'S THEME FOR THIS YEAR'S EVENT IS FOOD.
|
YUNJI'S PRIVATE LABEL FOOD BRANDS ARE A HIT WITH MEMBERS DURING 2022 ONLINE LUNAR NEW YEAR SHOPPING FESTIVAL
|
YJ
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2022-01-12 06:00:00
| null |
HANGZHOU, CHINA, JAN. 12, 2022 /PRNEWSWIRE/ -- YUNJI INC. ("YUNJI" OR THE "COMPANY") (NASDAQ: YJ), A LEADING MEMBERSHIP-BASED SOCIAL E-COMMERCE PLATFORM, ANNOUNCED THAT ITS PRIVATE LABEL BAIYUESHAN ("THE BRAND") BRAND CONTINUES TO BE A MEGAHIT AMONG CUSTOMERS. THE WOLFBERRY PUREE (THE "PRODUCT") THAT WAS RECENTLY LAUNCHED UNDER THE BRAND HAS GENERATED TENS OF MILLIONS OF RENMINBI IN SALES SINCE SEPTEMBER 2021.
|
YUNJI EXPANDS AND FURTHER DEVELOPS HIGH-END PRIVATE LABEL HEALTH FOOD BRAND BAIYUESHAN
|
YJ
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2022-01-07 06:00:00
| null |
HANGZHOU, CHINA, JAN. 7, 2022 /PRNEWSWIRE/ -- YUNJI INC. ("YUNJI" OR THE "COMPANY") (NASDAQ: YJ), A LEADING MEMBERSHIP-BASED SOCIAL E-COMMERCE PLATFORM, TODAY ANNOUNCED THE LAUNCH OF ITS PRIVATE LABEL QINGZIYANG ("THE BRAND") BRAND PROBIOTICS BOLUS SOLID BEVERAGE (THE "BEVERAGE"). THE BEVERAGE, WITH WINNER OF THE 2013 NOBEL PRIZE IN PHYSIOLOGY OR MEDICINE DR. RANDY W.
|
YUNJI ANNOUNCES LAUNCH OF NEW PRIVATE LABEL QINGZIYANG PROBIOTICS BEVERAGE
|
YJ
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-11-29 05:00:00
| null |
HANGZHOU, CHINA, NOV. 29, 2021 /PRNEWSWIRE/ -- YUNJI INC. ("YUNJI" OR THE "COMPANY") (NASDAQ: YJ), A LEADING MEMBERSHIP-BASED SOCIAL E-COMMERCE PLATFORM, TODAY ANNOUNCED ITS UNAUDITED FINANCIAL RESULTS FOR THE THIRD QUARTER ENDED SEPTEMBER 30, 2021 [1] . THIRD QUARTER 2021 HIGHLIGHTS TOTAL REVENUES IN THE THIRD QUARTER OF 2021 WERE RMB437.9 MILLION (US$68.0 MILLION), COMPARED WITH RMB1,066.7 MILLION IN THE SAME PERIOD OF 2020, PRIMARILY DUE TO THE COMPANY'S STRATEGY TO REFINE ITS PRODUCT SELECTION ACROSS ALL CATEGORIES AND CAREFULLY CURATE PRODUCTS TO IMPLEMENT ITS MEGAHIT PRODUCT POOL INITIATIVE FOCUSING ON THE DEVELOPMENT OF PRIVATE LABELS AND EXCLUSIVE PRODUCTS.
|
YUNJI ANNOUNCES THIRD QUARTER 2021 UNAUDITED FINANCIAL RESULTS
|
YJ
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-08-26 06:00:00
| null |
HANGZHOU, CHINA, AUG. 26, 2021 /PRNEWSWIRE/ -- YUNJI INC. ("YUNJI" OR THE "COMPANY") (NASDAQ: YJ), A LEADING MEMBERSHIP-BASED SOCIAL E-COMMERCE PLATFORM, TODAY ANNOUNCED ITS UNAUDITED FINANCIAL RESULTS FOR THE SECOND QUARTER ENDED JUNE 30, 2021 [1]. SECOND QUARTER 2021 HIGHLIGHTS TOTAL REVENUES IN THE SECOND QUARTER OF 2021 WERE RMB570.7 MILLION (US$88.4 MILLION), COMPARED WITH RMB1,486.9 MILLION IN THE SAME PERIOD OF 2020, PRIMARILY DUE TO THE COMPANY'S FOCUS ON REFINING ITS PRODUCT SELECTION ACROSS ALL CATEGORIES BY UPGRADING ITS STRATEGY TO CAREFULLY CURATE PRODUCTS THROUGH THE IMPLEMENTATION OF ITS MEGAHIT PRODUCT POOL INITIATIVE.
|
YUNJI ANNOUNCES SECOND QUARTER 2021 UNAUDITED FINANCIAL RESULTS
|
YJ
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-08-20 07:00:00
| null |
HANGZHOU, CHINA, AUG. 20, 2021 (GLOBE NEWSWIRE) -- YUNJI INC. (“YUNJI” OR THE “COMPANY”) (NASDAQ: YJ), A LEADING MEMBERSHIP-BASED SOCIAL E-COMMERCE PLATFORM, TODAY ANNOUNCED THAT IT PLANS TO RELEASE ITS SECOND QUARTER 2021 FINANCIAL RESULTS BEFORE THE MARKET OPENS ON THURSDAY, AUGUST 26, 2021. THE EARNINGS RELEASE WILL BE AVAILABLE ON THE COMPANY'S INVESTOR RELATIONS WEBSITE AT HTTPS://INVESTOR.YUNJIGLOBAL.COM/. THE COMPANY WILL HOLD A CONFERENCE CALL ON THURSDAY, AUGUST 26, 2021 AT 7:00 A.M. EASTERN TIME OR 7:00 P.M. BEIJING/HONG KONG TIME TO DISCUSS ITS EARNINGS.
|
YUNJI TO REPORT SECOND QUARTER 2021 FINANCIAL RESULTS ON AUGUST 26, 2021
|
YJ
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-07-31 09:00:00
| null |
HANGZHOU, CHINA, JULY 31, 2021 /PRNEWSWIRE/ -- YUNJI INC. ("YUNJI" OR THE "COMPANY") (NASDAQ: YJ), A LEADING MEMBERSHIP-BASED SOCIAL E-COMMERCE PLATFORM, TODAY ANNOUNCED THAT IT CELEBRATED THE 11TH ANNIVERSARY OF ITS PRIVATE LABEL SKINCARE BRAND SOLO LIFE. ESTABLISHED IN 2010 BY SHANGLUE XIAO, THE COMPANY'S SOLO LIFE BRAND OPENED ITS FIRST FLAGSHIP STORE ON TMALL, ALIBABA'S ONLINE RETAIL PLATFORM FOR BRAND-NAME GOODS.
|
YUNJI ANNOUNCES 11TH ANNIVERSARY OF SOLO LIFE, ITS PREMIER PRIVATE LABEL SKINCARE BRAND INCUBATED ON THE YUNJI PLATFORM
|
YJ
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-06-29 07:00:00
| null |
HANGZHOU, CHINA, JUNE 29, 2021 /PRNEWSWIRE/ -- YUNJI INC. ("YUNJI" OR THE "COMPANY") (NASDAQ: YJ), A LEADING MEMBERSHIP-BASED SOCIAL E-COMMERCE PLATFORM, TODAY ANNOUNCED THAT IT HAS OFFICIALLY LAUNCHED ITS "YUNJI 99" SPECIAL SALES PORTAL ON ITS YUNJI APP. PROMINENTLY FEATURED ON THE YUNJI APP'S MAIN PAGE, THE PORTAL FUNNELS THE PLATFORM'S CORE TRAFFIC TO A REFINED SELECTION OF MEGAHIT PRODUCTS ACROSS ALL CATEGORIES.
|
YUNJI LAUNCHES NEW "YUNJI 99" SPECIAL SALES PORTAL ON MOBILE APP
|
YJ
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-05-27 06:00:00
| null |
HANGZHOU, CHINA, MAY 27, 2021 /PRNEWSWIRE/ -- YUNJI INC. ("YUNJI" OR THE "COMPANY") (NASDAQ: YJ), A LEADING MEMBERSHIP-BASED SOCIAL E-COMMERCE PLATFORM, TODAY ANNOUNCED ITS UNAUDITED FINANCIAL RESULTS FOR THE FIRST QUARTER ENDED MARCH 31, 2021 [1]. FIRST QUARTER 2021 HIGHLIGHTS TOTAL REVENUES IN THE FIRST QUARTER OF 2021 WERE RMB675.4 MILLION (US$103.1 MILLION), COMPARED WITH RMB1,649.2 MILLION IN THE SAME PERIOD OF 2020, PRIMARILY DUE TO THE COMPANY'S FOCUS ON UPGRADING ITS STRATEGY OF CAREFULLY CURATING PRODUCTS THROUGH THE IMPLEMENTATION OF ITS MEGAHIT PRODUCT POOL INITIATIVE TO REFINE ITS PRODUCT SELECTIONS ACROSS ALL PLATFORM CATEGORIES, WHICH IS IN LINE WITH THE COMPANY'S LONG-TERM GROWTH PLAN.
|
YUNJI ANNOUNCES FIRST QUARTER 2021 UNAUDITED FINANCIAL RESULTS
|
YJ
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-05-21 07:00:00
| null |
HANGZHOU, CHINA, MAY 21, 2021 (GLOBE NEWSWIRE) -- YUNJI INC. (“YUNJI” OR THE “COMPANY”) (NASDAQ: YJ), A LEADING MEMBERSHIP-BASED SOCIAL E-COMMERCE PLATFORM, TODAY ANNOUNCED THAT IT PLANS TO RELEASE ITS FIRST QUARTER 2021 FINANCIAL RESULTS BEFORE THE MARKET OPENS ON THURSDAY, MAY 27, 2021. THE EARNINGS RELEASE WILL BE AVAILABLE ON THE COMPANY'S INVESTOR RELATIONS WEBSITE AT HTTPS://INVESTOR.YUNJIGLOBAL.COM/. THE COMPANY WILL HOST A CONFERENCE CALL ON THURSDAY, MAY 27, 2021, AT 7:00 AM EASTERN TIME OR 7:00 PM BEIJING/HONG KONG TIME TO DISCUSS ITS EARNINGS.
|
YUNJI TO REPORT FIRST QUARTER 2021 FINANCIAL RESULTS ON MAY 27, 2021
|
YJ
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-04-26 09:20:00
| null |
HANGZHOU, CHINA, APRIL 26, 2021 (GLOBE NEWSWIRE) -- YUNJI INC. (“YUNJI” OR THE “COMPANY”) (NASDAQ: YJ), A LEADING MEMBERSHIP-BASED SOCIAL E-COMMERCE PLATFORM, TODAY ANNOUNCED THAT IT HAS FILED ITS ANNUAL REPORT ON FORM 20-F FOR THE FISCAL YEAR ENDED DECEMBER 31, 2020 WITH THE SECURITIES AND EXCHANGE COMMISSION ON APRIL 26, 2021 EASTERN TIME. THE ANNUAL REPORT CAN BE ACCESSED ON THE COMPANY'S INVESTOR RELATIONS WEBSITE AT HTTPS://INVESTOR.YUNJIGLOBAL.COM/. THE COMPANY WILL PROVIDE A HARD COPY OF ITS ANNUAL REPORT CONTAINING THE AUDITED CONSOLIDATED FINANCIAL STATEMENTS, FREE OF CHARGE, TO ITS SHAREHOLDERS AND ADS HOLDERS UPON REQUEST. REQUESTS SHOULD BE SUBMITTED TO YUNJI.IR@ICRINC.COM.
|
YUNJI FILED 2020 ANNUAL REPORT ON FORM 20-F
|
YJ
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-04-23 08:10:00
| null |
HANGZHOU, CHINA, APRIL 23, 2021 (GLOBE NEWSWIRE) -- YUNJI INC. (“YUNJI” OR THE “COMPANY”) (NASDAQ: YJ), A LEADING MEMBERSHIP-BASED SOCIAL E-COMMERCE PLATFORM, TODAY ANNOUNCED THAT IT HAS APPOINTED MR. WEI YE AS EXECUTIVE PRESIDENT OF THE COMPANY, WHICH ALREADY TOOK EFFECT IN APRIL 2021.
|
YUNJI ANNOUNCES APPOINTMENT OF EXECUTIVE PRESIDENT
|
YJ
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-03-22 05:30:00
| null |
HANGZHOU, CHINA, MARCH 22, 2021 (GLOBE NEWSWIRE) -- YUNJI INC. (“YUNJI” OR THE “COMPANY”) (NASDAQ: YJ), A LEADING MEMBERSHIP-BASED SOCIAL E-COMMERCE PLATFORM, TODAY ANNOUNCED ITS UNAUDITED FINANCIAL RESULTS FOR THE FOURTH QUARTER AND FISCAL YEAR ENDED DECEMBER 31, 20201.
|
YUNJI ANNOUNCES FOURTH QUARTER AND FISCAL YEAR 2020 UNAUDITED FINANCIAL RESULTS
|
YJ
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-02-25 06:00:00
| null |
HANGZHOU, CHINA, FEB. 25, 2021 (GLOBE NEWSWIRE) -- YUNJI INC. (“YUNJI” OR THE “COMPANY”) (NASDAQ: YJ), A LEADING MEMBERSHIP-BASED SOCIAL E-COMMERCE PLATFORM, TODAY REPORTED THE RESULTS OF ITS HOLIDAY CELEBRATION SHOPPING CAMPAIGNS AND CONTINUOUS E-COMMERCE SERVICE FOR PLATFORM MEMBERS DURING THE CHINA MINISTRY OF COMMERCE'S 2021 ONLINE LUNAR NEW YEAR SHOPPING FESTIVAL EVENT.
|
YUNJI PROVIDES MEMBERS WITH SEAMLESS E-COMMERCE SHOPPING EXPERIENCE DURING 2021 LUNAR NEW YEAR
|
YJ
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-01-29 06:00:00
| null |
IN RESPONSE TO RISING USER DEMAND FOR HIGH-QUALITY FOOD PRODUCTS IN RESPONSE TO RISING USER DEMAND FOR HIGH-QUALITY FOOD PRODUCTS
|
YUNJI TO LAUNCH FIRST-EVER PRIVATE LABEL FOOD BRAND LI BA TIAN
|
YJ
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-11-26 05:10:00
| null |
HANGZHOU, CHINA, NOV. 26, 2020 (GLOBE NEWSWIRE) -- YUNJI INC. (“YUNJI” OR THE “COMPANY”) (NASDAQ: YJ), A LEADING MEMBERSHIP-BASED SOCIAL E-COMMERCE PLATFORM, TODAY ANNOUNCED ITS UNAUDITED FINANCIAL RESULTS FOR THE THIRD QUARTER ENDED SEPTEMBER 30, 20201.
|
YUNJI ANNOUNCES THIRD QUARTER 2020 UNAUDITED FINANCIAL RESULTS
|
YJ
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-11-25 07:28:00
| null |
HANGZHOU, CHINA, NOV. 25, 2020 (GLOBE NEWSWIRE) -- IN A RELEASE ISSUED ON NOVEMBER, 24 2020 BY YUNJI INC. (NASDAQ: YJ), PLEASE NOTE THAT MULTIPLE CHANGES THROUGHOUT THE TEXT HAVE BEEN IMPLEMENTED, INCLUDING IN THE HEADLINE.
|
CORRECTION - YUNJI INC.
|
YJ
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-11-24 16:30:00
| null |
HANGZHOU, CHINA, NOV. 25, 2020 (GLOBE NEWSWIRE) -- YUNJI INC. (“YUNJI” OR THE “COMPANY”) (NASDAQ: YJ), A LEADING MEMBERSHIP-BASED SOCIAL E-COMMERCE PLATFORM, TODAY ANNOUNCED THAT IT HAS SIGNED A COOPERATIVE FRAMEWORK AGREEMENT (THE “AGREEMENT”) WITH DOUYIN, A LEADING CHINESE LIVE STREAMING PLATFORM OWNED BY BYTEDANCE. THE AGREEMENT'S ESTABLISHMENT IS IN LINE WITH THE COMPANY'S STRATEGY OF EXPLORING THE LIVE STREAMING POTENTIAL OF EXTERNAL PLATFORMS IN SUCH AREAS AS PRODUCT SUPPLY CHAIN, E-COMMERCE STREAMER RESOURCES, AND PLATFORM TRAFFIC.
|
YUNJI ANNOUNCES THE SIGNING OF A COOPERATIVE FRAMEWORK AGREEMENT WITH DOUYIN
|
YJ
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-10-30 06:00:00
| null |
HANGZHOU, CHINA, OCT. 30, 2020 (GLOBE NEWSWIRE) -- YUNJI INC. (“YUNJI” OR THE “COMPANY”) (NASDAQ: YJ), A LEADING MEMBERSHIP-BASED SOCIAL E-COMMERCE PLATFORM, TODAY ANNOUNCED PLANS TO FORM NEW PARTNERSHIPS WITH LEADING AGRICULTURAL BRANDS TO BETTER PROMOTE THEIR PRODUCTS ACROSS DIFFERENT REGIONS OF CHINA. THIS INITIATIVE IS PART OF THE COMPANY'S ONGOING SUPPLY CHAIN DIFFERENTIATION PROGRAM, WHICH AIMS TO USE YUNJI'S PLATFORM AND RESOURCES TO OFFER DIFFERENTIATED PRODUCTS, BETTER SUPPORT QUALITY SUPPLIERS, AND PROMOTE ECONOMIC OPPORTUNITIES THROUGH E-COMMERCE. THESE NEW PARTNERSHIPS WILL ALSO ENHANCE THE COMPANY'S VALUE PROPOSITION FOR MEMBERS BY RESPONSIBLY AND EFFICIENTLY SOURCING QUALITY PRODUCTS AT ATTRACTIVE PRICES.
|
YUNJI STRENGTHENS SUPPORT OF REGIONAL AGRICULTURAL PROVIDERS THROUGH SUPPLY CHAIN DIFFERENTIATION PROGRAM
|
YJ
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-08-25 08:30:00
| null |
YUNJI ANNOUNCES SECOND QUARTER 2020 UNAUDITED FINANCIAL RESULTS.Q2 LOSS PER SHARE $0.001.TOTAL REVENUE IN Q2 WERE RMB 1,486.9 MILLION ($210.5 MILLION), COMPARED WITH RMB 3,064.1 MILLION.GMV IN Q2 WAS RMB 7.8 BILLION ($1.1 BILLION) VERSUS RMB 8.2 BILLION.
|
YUNJI POSTS Q2 LOSS PER SHARE OF $0.001
|
YJ
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-06-03 10:30:00
| null |
YUNJI ANNOUNCES FIRST QUARTER 2020 UNAUDITED FINANCIAL RESULTS.Q1 LOSS PER SHARE $0.001.QUARTERLY TOTAL REVENUES $232.9 MILLION.
|
YUNJI REPORTS FIRST QUARTER 2020 UNAUDITED FINANCIAL RESULTS
|
YJ
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-03-24 07:30:00
| null |
YUNJI ANNOUNCES FOURTH QUARTER AND FISCAL YEAR 2019 UNAUDITED FINANCIAL RESULTS.Q4 LOSS PER SHARE $0.0003.TOTAL REVENUES IN Q4 OF 2019 WERE RMB2,449.4 MILLION (US$351.8 MILLION), COMPARED WITH RMB4,465.9 MILLION IN SAME PERIOD OF 2018.CUMULATIVE MEMBERS AS OF DECEMBER 31, 2019 INCREASED BY 12.3% TO 13.8 MILLION FROM 12.3 MILLION AS OF SEPTEMBER 30, 2019.GMV IN Q4 OF 2019 INCREASED BY 36.1% YEAR OVER YEAR TO RMB11.0 BILLION (US$1.6 BILLION).TRANSACTING MEMBERS IN TWELVE MONTHS ENDED DECEMBER 31, 2019, INCREASED BY 57.4% YEAR OVER YEAR TO 9.6 MILLION FROM 6.1 MILLION.BUSINESS IS EXPERIENCING SOME SHORT-TERM IMPACTS FROM COVID-19 OUTBREAK.
|
YUNJI REPORTS Q4 LOSS PER SHARE $0.0003
|
YJ
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2019-12-02 07:30:00
| null |
YUNJI ANNOUNCES THIRD QUARTER 2019 UNAUDITED FINANCIAL RESULTS.Q3 LOSS PER SHARE $0.003.TOTAL REVENUES IN Q3 OF 2019 WERE RMB2,773.1 MILLION (US$388.0 MILLION), COMPARED WITH RMB3,084.0 MILLION IN SAME PERIOD OF 2018.GMV IN Q3 OF 2019 INCREASED BY 69.8% YEAR OVER YEAR TO RMB9.2 BILLION (US$1.3 BILLION) FROM RMB5.4 BILLION IN SAME PERIOD OF 2018.
|
YUNJI REPORTS Q3 LOSS PER SHARE $0.003
|
YJ
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2019-12-01 22:30:00
| null |
ROSEN LAW FIRM REMINDS PURCHASERS OF THE SECURITIES OF YUNJI INC. WHO PURCHASED OR OTHERWISE ACQUIRED YUNJI SECURITIES PURSUANT AND/OR TRACEABLE TO YUNJI'S REGISTRATION STATEMENT ISSUED IN CONNECTION WITH YUNJI'S MAY 2019 INITIAL PUBLIC STOCK OFFERING OF THE IMPORTANT JANUARY 13, 2020 LEAD PLAINTIFF DEADLINE IN THE SECURITIES CLASS ACTION. THE LAWSUIT SEEKS TO RECOVER DAMAGES FOR YUNJI INVESTORS UNDER THE FEDERAL SECURITIES LAWS.
|
ROSEN REMINDS YUNJI INC. INVESTORS OF IMPORTANT DEADLINE IN SECURITIES CLASS ACTION
|
YJ
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2019-11-19 22:30:00
| null |
YUNJI INC., Q3 2019 EARNINGS CALL, DEC 02, 2019
|
YUNJI INC., Q3 2019 EARNINGS CALL, DEC 02, 2019
|
YJ
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2019-11-12 22:30:00
| null |
GLANCY PRONGAY & MURRAY LLP ANNOUNCED THAT IT HAS FILED A CLASS ACTION LAWSUIT IN THE UNITED STATES DISTRICT COURT FOR THE EASTERN DISTRICT OF NEW YORK CAPTIONED CHEN V. YUNJI INC. ET AL., ON BEHALF OF PERSONS AND ENTITIES THAT PURCHASED OR OTHERWISE ACQUIRED YUNJI INC. AMERICAN DEPOSITARY SHARES PURSUANT AND/OR TRACEABLE TO THE REGISTRATION STATEMENT AND PROSPECTUS ISSUED IN CONNECTION WITH THE COMPANY’S MAY 2019 INITIAL PUBLIC OFFERING. PLAINTIFF PURSUES CLAIMS UNDER THE SECURITIES ACT OF 1933. ON MAY 3, 2019, THE COMPANY HELD ITS IPO IN WHICH IT SOLD 11,217,447 SHARES FOR $11.00 PER SHARE. ON AUGUST 22, 2019, THE COMPANY DISCLOSED A SUPPLY CHAIN RESTRUCTURING THAT SHIFTED PART OF ITS MERCHANDISE SALES TO ITS MARKETPLACE PLATFORM, RESULTING IN A YEAR-OVER-YEAR DECREASE IN TOTAL REVENUES FOR SECOND QUARTER 2019. ON THIS NEWS, THE COMPANY’S SHARE PRICE FELL $1.21, NEARLY 11%, TO CLOSE AT $9.39 PER SHARE ON AUGUST 22, 2019, THEREBY INJURING INVESTORS. THE SHARE PRICE CONTINUED TO DECLINE BY $3.34, OR OVER 35%, OVER THE NEXT THREE CONSECUTIVE TRADING SESSIONS TO CLOSE AT $6.05 PER SHARE ON AUGUST 27, 2019, THEREBY INJURING INVESTORS FURTHER. BY THE COMMENCEMENT OF THIS ACTION, YUNJI’S SHARES WERE TRADING AS LOW AS $4.40 PER SHARE, A NEARLY 60% DECLINE FROM THE $11 PER SHARE IPO PRICE. THE REGISTRATION STATEMENT WAS FALSE AND MISLEADING AND OMITTED TO STATE MATERIAL ADVERSE FACTS. SPECIFICALLY, DEFENDANTS FAILED TO DISCLOSE TO INVESTORS THAT THE COMPANY WAS SHIFTING CERTAIN OF ITS SALES TO ITS MARKETPLACE PLATFORM, SUPPLY CHAIN RESTRUCTURING WAS LIKELY TO DISRUPT YUNJI’S RELATIONSHIPS WITH SUPPLIERS, SUPPLY CHAIN RESTRUCTURING WAS LIKELY TO HAVE AN ADVERSE IMPACT ON THE COMPANY’S FINANCIAL RESULTS AND AS A RESULT OF THE FOREGOING, DEFENDANTS’ POSITIVE STATEMENTS ABOUT THE COMPANY’S BUSINESS, OPERATIONS, AND PROSPECTS, WERE MATERIALLY MISLEADING AND/OR LACKED A REASONABLE BASIS.
|
GLANCY PRONGAY & MURRAY LLP FILES SECURITIES CLASS ACTION ON BEHALF OF YUNJI INC. INVESTORS
|
YJ
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2019-10-29 22:30:00
| null |
CERTAIN ORDINARY SHARES OF YUNJI INC. ARE SUBJECT TO A LOCK-UP AGREEMENT ENDING ON 30-OCT-2019. THESE ORDINARY SHARES WILL BE UNDER LOCKUP FOR 181 DAYS STARTING FROM 2-MAY-2019 TO 30-OCT-2019.
DETAILS:
THE DIRECTORS AND OFFICERS AND THE HOLDERS HAVE AGREED THAT, THEY WILL NOT DIRECTLY OR INDIRECTLY, OFFER, SELL, CONTRACT TO SELL, PLEDGE, GRANT OR DISPOSE OF OR HEDGE, ANY ORDINARY SHARES OR AMERICAN DEPOSITARY SHARES OR ANY SECURITIES CONVERTIBLE INTO OR EXERCISABLE OR EXCHANGEABLE FOR ORDINARY SHARES OR AMERICAN DEPOSITARY SHARES, FOR A PERIOD OF 180 DAYS AFTER THE DATE OF THE PROSPECTUS WITHOUT THE PRIOR CONSENT OF MORGAN STANLEY & CO. LLC, CREDIT SUISSE SECURITIES (USA) LLC, J.P. MORGAN SECURITIES LLC AND CHINA INTERNATIONAL CAPITAL CORPORATION HONG KONG SECURITIES LIMITED.
|
CERTAIN ORDINARY SHARES OF YUNJI INC. ARE SUBJECT TO A LOCK-UP AGREEMENT ENDING ON 30-OCT-2019.
|
YJ
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2023-05-26 09:00:00
| null |
NEW YORK, MAY 26, 2023 (GLOBE NEWSWIRE) -- Y-MABS THERAPEUTICS, INC. (THE “COMPANY” OR “Y-MABS”) (NASDAQ: YMAB) A COMMERCIAL-STAGE BIOPHARMACEUTICAL COMPANY FOCUSED ON THE DEVELOPMENT AND COMMERCIALIZATION OF NOVEL, ANTIBODY-BASED THERAPEUTIC PRODUCTS FOR THE TREATMENT OF CANCER, TODAY ANNOUNCED THAT A POSTER PRESENTATION FEATURING INTERIM CLINICAL DATA ON NAXITAMAB, A RECOMBINANT, HUMANIZED ANTI-GD2 MONOCLONAL ANTIBODY, IN COMBINATION WITH GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (“GM-CSF”) WILL BE PRESENTED AT THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY (“ASCO”) ANNUAL MEETING TO BE HELD JUNE 2-6, 2023, IN CHICAGO, ILLINOIS.
|
Y-MABS ANNOUNCES PRESENTATION OF NAXITAMAB DATA AT ASCO
|
YMAB
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2023-05-23 09:00:00
| null |
NEW YORK, MAY 23, 2023 (GLOBE NEWSWIRE) -- Y-MABS THERAPEUTICS, INC. (THE “COMPANY” OR “Y-MABS”) (NASDAQ: YMAB) A COMMERCIAL-STAGE BIOPHARMACEUTICAL COMPANY FOCUSED ON THE DEVELOPMENT AND COMMERCIALIZATION OF NOVEL, ANTIBODY-BASED THERAPEUTIC PRODUCTS FOR THE TREATMENT OF CANCER, TODAY ANNOUNCED THAT THE BRAZILIAN HEALTH REGULATORY AGENCY, AGÊNCIA NACIONAL DE VIGILÂNCIA SANITÁRIA (“ANVISA”) HAS GRANTED MARKETING AUTHORIZATION FOR DANYELZA (NAXITAMAB-GQGK) 40MG/10ML INJECTION. DANYELZA WILL BE MARKETED IN BRAZIL BY Y-MABS' PARTNER ADIUM PHARMA S.A. (“ADIUM”).
|
Y-MABS' DANYELZA® (NAXITAMAB-GQGK) FOR THE TREATMENT OF HIGH-RISK NEUROBLASTOMA APPROVED IN BRAZIL
|
YMAB
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2023-03-20 05:45:00
| null |
NEW YORK , MARCH 20, 2023 /PRNEWSWIRE/ -- ATTENTION Y-MABS THERAPEUTICS, INC. ("Y-MABS") (NASDAQ: YMAB) SHAREHOLDERS: THE LAW OFFICES OF VINCENT WONG ANNOUNCE THAT A CLASS ACTION LAWSUIT HAS COMMENCED ON BEHALF OF INVESTORS. THIS LAWSUIT IS ON BEHALF OF PERSONS OR ENTITIES WHO PURCHASED SHARES OF Y-MABS THERAPEUTICS, INC. COMMON STOCK ON THE OPEN MARKET OR PURSUANT TO REGISTRATION STATEMENTS FILED WITH THE U.S. SECURITIES AND EXCHANGE COMMISSION DURING THE PERIOD OCTOBER 6, 2020 THROUGH OCTOBER 28, 2022, INCLUSIVE.
|
CLASS ACTION ALERT: THE LAW OFFICES OF VINCENT WONG REMIND Y-MABS INVESTORS OF A LEAD PLAINTIFF DEADLINE OF MARCH 20, 2023
|
YMAB
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2023-03-18 07:00:00
| null |
NEW YORK , MARCH 18, 2023 /PRNEWSWIRE/ -- FARUQI & FARUQI, LLP, A LEADING NATIONAL SECURITIES LAW FIRM, IS INVESTIGATING POTENTIAL CLAIMS AGAINST Y-MABS THERAPEUTICS, INC. ("Y-MABS" OR THE "COMPANY") (NASDAQ: YMAB) AND REMINDS INVESTORS OF THE MARCH 20, 2023 DEADLINE TO SEEK THE ROLE OF LEAD PLAINTIFF IN A FEDERAL SECURITIES CLASS ACTION THAT HAS BEEN FILED AGAINST THE COMPANY. IF YOU SUFFERED LOSSES EXCEEDING $100,000 INVESTING IN Y-MABS STOCK OR OPTIONS BETWEEN OCTOBER 6, 2020 AND OCTOBER 28, 2022 AND WOULD LIKE TO DISCUSS YOUR LEGAL RIGHTS, CALL FARUQI & FARUQI PARTNER JOSH WILSON DIRECTLY AT 877-247-4292 OR 212-983-9330 (EXT.
|
Y-MABS INVESTOR ALERT: SECURITIES LITIGATION PARTNER JAMES (JOSH) WILSON ENCOURAGES INVESTORS WHO SUFFERED LOSSES EXCEEDING $100,000 IN Y-MABS TO CONTACT HIM DIRECTLY TO DISCUSS THEIR OPTIONS
|
YMAB
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2023-03-17 10:00:00
| null |
LOS ANGELES--(BUSINESS WIRE)--THE LAW OFFICES OF FRANK R. CRUZ REMINDS INVESTORS OF THE UPCOMING MARCH 20, 2023 DEADLINE TO FILE A LEAD PLAINTIFF MOTION IN THE CLASS ACTION FILED ON BEHALF OF INVESTORS WHO ACQUIRED Y-MABS THERAPEUTICS, INC. (“Y-MABS” OR THE “COMPANY”) (NASDAQ: YMAB) COMMON STOCK BETWEEN OCTOBER 6, 2020 AND OCTOBER 28, 2022, INCLUSIVE (THE “CLASS PERIOD”). IF YOU ARE A SHAREHOLDER WHO SUFFERED A LOSS, CLICK HERE TO PARTICIPATE.
|
THE LAW OFFICES OF FRANK R. CRUZ REMINDS INVESTORS OF LOOMING DEADLINE IN THE CLASS ACTION LAWSUIT AGAINST Y-MABS THERAPEUTICS, INC. (YMAB)
|
YMAB
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2023-03-17 05:45:00
| null |
NEW YORK , MARCH 17, 2023 /PRNEWSWIRE/ -- JAKUBOWITZ LAW ANNOUNCES THAT A SECURITIES FRAUD CLASS ACTION LAWSUIT HAS COMMENCED ON BEHALF OF SHAREHOLDERS OF Y-MABS THERAPEUTICS, INC. (NASDAQ: YMAB). TO RECEIVE UPDATES ON THE LAWSUIT, FILL OUT THE FORM: HTTPS://CLAIMYOURLOSS.COM/SECURITIES/Y-MABS-THERAPEUTICS-INC-LOSS-SUBMISSION-FORM/?ID=37347&FROM=4 THIS LAWSUIT IS ON BEHALF OF PERSONS OR ENTITIES WHO PURCHASED SHARES OF Y-MABS THERAPEUTICS, INC. COMMON STOCK ON THE OPEN MARKET OR PURSUANT TO REGISTRATION STATEMENTS FILED WITH THE U.S. SECURITIES AND EXCHANGE COMMISSION DURING THE PERIOD OCTOBER 6, 2020 THROUGH OCTOBER 28, 2022, INCLUSIVE.
|
YMAB SHAREHOLDER ALERT: JAKUBOWITZ LAW REMINDS Y-MABS SHAREHOLDERS OF A LEAD PLAINTIFF DEADLINE OF MARCH 20, 2023
|
YMAB
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2023-03-16 05:45:00
| null |
NEW YORK , MARCH 16, 2023 /PRNEWSWIRE/ -- LEVI & KORSINSKY, LLP NOTIFIES INVESTORS IN Y-MABS THERAPEUTICS, INC. ("Y-MABS" OR THE "COMPANY") (NASDAQ: YMAB) OF A CLASS ACTION SECURITIES LAWSUIT. CLASS DEFINITION: THE LAWSUIT SEEKS TO RECOVER LOSSES ON BEHALF OF Y-MABS INVESTORS WHO WERE ADVERSELY AFFECTED BY ALLEGED SECURITIES FRAUD.
|
YMAB LAWSUIT ALERT: LEVI & KORSINSKY NOTIFIES Y-MABS THERAPEUTICS, INC. INVESTORS OF A CLASS ACTION LAWSUIT AND UPCOMING DEADLINE
|
YMAB
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2023-03-15 18:05:00
| null |
LOS ANGELES, CA / ACCESSWIRE / MARCH 15, 2023 / THE SCHALL LAW FIRM, A NATIONAL SHAREHOLDER RIGHTS LITIGATION FIRM, REMINDS INVESTORS OF A CLASS ACTION LAWSUIT AGAINST Y-MABS THERAPEUTICS, INC. ("Y-MABS" OR "THE COMPANY") (NASDAQ:YMAB) FOR VIOLATIONS OF 10(B) AND 20(A) OF THE SECURITIES EXCHANGE ACT OF 1934 AND RULE 10B-5 PROMULGATED THEREUNDER BY THE U.S. SECURITIES AND EXCHANGE COMMISSION. INVESTORS WHO PURCHASED THE COMPANY'S SECURITIES BETWEEN OCTOBER 6, 2020 AND OCTOBER 28, 2022, INCLUSIVE (THE ''CLASS PERIOD''), ARE ENCOURAGED TO CONTACT THE FIRM BEFORE MARCH 20, 2023.
|
FINAL DEADLINE IMMINENT: THE SCHALL LAW FIRM ENCOURAGES INVESTORS IN Y-MABS THERAPEUTICS, INC. WITH LOSSES OF $100,000 TO CONTACT THE FIRM
|
YMAB
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2023-03-15 17:30:00
| null |
NEW YORK , MARCH 15, 2023 /PRNEWSWIRE/ -- WHY: ROSEN LAW FIRM, A GLOBAL INVESTOR RIGHTS LAW FIRM, REMINDS PURCHASERS OF THE SECURITIES OF Y-MABS THERAPEUTICS, INC. (NASDAQ: YMAB) BETWEEN OCTOBER 6, 2020 AND OCTOBER 28, 2022, BOTH DATES INCLUSIVE (THE "CLASS PERIOD"), OF THE IMPORTANT MARCH 20, 2023 LEAD PLAINTIFF DEADLINE. SO WHAT: IF YOU PURCHASED Y-MABS SECURITIES YOU MAY BE ENTITLED TO COMPENSATION WITHOUT PAYMENT OF ANY OUT OF POCKET FEES OR COSTS THROUGH A CONTINGENCY FEE ARRANGEMENT.
|
ROSEN, RECOGNIZED INVESTOR COUNSEL, ENCOURAGES Y-MABS THERAPEUTICS, INC. INVESTORS WITH LOSSES TO SECURE COUNSEL BEFORE IMPORTANT MARCH 20 DEADLINE IN SECURITIES CLASS ACTION - YMAB
|
YMAB
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2023-03-15 10:00:00
| null |
BENSALEM, PA. , MARCH 15, 2023 /PRNEWSWIRE/ -- LAW OFFICES OF HOWARD G.
|
YMAB INVESTORS HAVE OPPORTUNITY TO LEAD Y-MABS THERAPEUTICS, INC. SECURITIES FRAUD LAWSUIT
|
YMAB
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2023-03-15 01:45:00
| null |
DID YOU LOSE MONEY ON INVESTMENTS IN Y-MABS THERAPEUTICS? IF SO, PLEASE VISIT Y-MABS THERAPEUTICS, INC. SHAREHOLDER CLASS ACTION LAWSUIT OR CONTACT PETER ALLOCCO AT (212) 951-2030 OR PALLOCCO@BERNLIEB.COM TO DISCUSS YOUR RIGHTS.
|
Y-MABS THERAPEUTICS, INC. (NASDAQ: YMAB) SHAREHOLDER CLASS ACTION ALERT: BERNSTEIN LIEBHARD LLP REMINDS INVESTORS OF THE DEADLINE TO FILE A LEAD PLAINTIFF MOTION IN A SECURITIES CLASS ACTION LAWSUIT AGAINST Y-MABS THERAPEUTICS, INC. (NASDAQ: YMAB)
|
YMAB
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2023-03-14 05:45:00
| null |
NEW YORK , MARCH 14, 2023 /PRNEWSWIRE/ -- THE KLEIN LAW FIRM ANNOUNCES THAT A CLASS ACTION COMPLAINT HAS BEEN FILED ON BEHALF OF SHAREHOLDERS OF Y-MABS THERAPEUTICS, INC. (NASDAQ: YMAB) ALLEGING THAT THE COMPANY VIOLATED FEDERAL SECURITIES LAWS. THIS LAWSUIT IS ON BEHALF OF PERSONS OR ENTITIES WHO PURCHASED SHARES OF Y-MABS THERAPEUTICS, INC. COMMON STOCK ON THE OPEN MARKET OR PURSUANT TO REGISTRATION STATEMENTS FILED WITH THE U.S. SECURITIES AND EXCHANGE COMMISSION DURING THE PERIOD OCTOBER 6, 2020 THROUGH OCTOBER 28, 2022, INCLUSIVE.LEAD PLAINTIFF DEADLINE: MARCH 20, 2023 NO OBLIGATION OR COST TO YOU.
|
YMAB ALERT: THE KLEIN LAW FIRM ANNOUNCES A LEAD PLAINTIFF DEADLINE OF MARCH 20, 2023 IN THE CLASS ACTION FILED ON BEHALF OF Y-MABS THERAPEUTICS, INC. SHAREHOLDERS
|
YMAB
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2023-03-13 19:15:00
| null |
LOS ANGELES, CA / ACCESSWIRE / MARCH 13, 2023 / THE SCHALL LAW FIRM , A NATIONAL SHAREHOLDER RIGHTS LITIGATION FIRM, REMINDS INVESTORS OF A CLASS ACTION LAWSUIT AGAINST Y-MABS THERAPEUTICS, INC. ("Y-MABS" OR "THE COMPANY") (NASDAQ:YMAB) FOR VIOLATIONS OF 10(B) AND 20(A) OF THE SECURITIES EXCHANGE ACT OF 1934 AND RULE 10B-5 PROMULGATED THEREUNDER BY THE U.S. SECURITIES AND EXCHANGE COMMISSION. INVESTORS WHO PURCHASED THE COMPANY'S SECURITIES BETWEEN OCTOBER 6, 2020 AND OCTOBER 28, 2022, INCLUSIVE (THE ''CLASS PERIOD''), ARE ENCOURAGED TO CONTACT THE FIRM BEFORE MARCH 20, 2023.
|
FINAL DEADLINE APPROACHING: THE SCHALL LAW FIRM ENCOURAGES INVESTORS IN Y-MABS THERAPEUTICS, INC. WITH LOSSES OF $100,000 TO CONTACT THE FIRM
|
YMAB
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2023-03-13 18:45:00
| null |
LOS ANGELES, CA / ACCESSWIRE / MARCH 13, 2023 / THE SCHALL LAW FIRM, A NATIONAL SHAREHOLDER RIGHTS LITIGATION FIRM, REMINDS INVESTORS OF A CLASS ACTION LAWSUIT AGAINST Y-MABS THERAPEUTICS, INC. ("Y-MABS" OR "THE COMPANY") (NASDAQ:YMAB) FOR VIOLATIONS OF 10(B) AND 20(A) OF THE SECURITIES EXCHANGE ACT OF 1934 AND RULE 10B-5 PROMULGATED THEREUNDER BY THE U.S. SECURITIES AND EXCHANGE COMMISSION. INVESTORS WHO PURCHASED THE COMPANY'S SECURITIES BETWEEN OCTOBER 6, 2020 AND OCTOBER 28, 2022, INCLUSIVE (THE ''CLASS PERIOD''), ARE ENCOURAGED TO CONTACT THE FIRM BEFORE MARCH 20, 2023.
|
INVESTOR ACTION ALERT: THE SCHALL LAW FIRM ENCOURAGES INVESTORS IN Y-MABS THERAPEUTICS, INC. WITH LOSSES OF $100,000 TO CONTACT THE FIRM
|
YMAB
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2023-03-13 16:35:00
| null |
NEW YORK , MARCH 13, 2023 /PRNEWSWIRE/ -- POMERANTZ LLP IS INVESTIGATING CLAIMS ON BEHALF OF INVESTORS OF Y-MABS THERAPEUTICS, INC. ("Y-MABS" OR THE "COMPANY") (NASDAQ: YMAB). SUCH INVESTORS ARE ADVISED TO CONTACT ROBERT S.
|
SHAREHOLDER ALERT: POMERANTZ LAW FIRM INVESTIGATES CLAIMS ON BEHALF OF INVESTORS OF Y-MABS THERAPEUTICS, INC. - YMAB
|
YMAB
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2023-03-13 11:00:00
| null |
NEW YORK--(BUSINESS WIRE)--ATTORNEY ADVERTISING--BRONSTEIN, GEWIRTZ & GROSSMAN, LLC NOTIFIES INVESTORS THAT A CLASS ACTION LAWSUIT HAS BEEN FILED AGAINST Y-MABS THERAPEUTICS, INC. (“Y-MABS” OR THE “COMPANY”) (NASDAQ: YMAB) AND CERTAIN OF ITS OFFICERS, ON BEHALF OF ALL PERSONS AND ENTITIES THAT PURCHASED, OR OTHERWISE ACQUIRED Y-MABS SECURITIES BETWEEN OCTOBER 6, 2020 AND OCTOBER 28, 2022, BOTH DATES INCLUSIVE (THE “CLASS PERIOD”).
|
BRONSTEIN, GEWIRTZ & GROSSMAN, LLC NOTIFIES Y-MABS THERAPEUTICS, INC. (YMAB) INVESTORS OF CLASS ACTION AND TO ACTIVELY PARTICIPATE
|
YMAB
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2023-03-13 05:45:00
| null |
NEW YORK , MARCH 13, 2023 /PRNEWSWIRE/ -- ATTENTION Y-MABS THERAPEUTICS, INC. ("Y-MABS") (NASDAQ: YMAB) SHAREHOLDERS: THE LAW OFFICES OF VINCENT WONG ANNOUNCE THAT A CLASS ACTION LAWSUIT HAS COMMENCED ON BEHALF OF INVESTORS. THIS LAWSUIT IS ON BEHALF OF PERSONS OR ENTITIES WHO PURCHASED SHARES OF Y-MABS THERAPEUTICS, INC. COMMON STOCK ON THE OPEN MARKET OR PURSUANT TO REGISTRATION STATEMENTS FILED WITH THE U.S. SECURITIES AND EXCHANGE COMMISSION DURING THE PERIOD OCTOBER 6, 2020 THROUGH OCTOBER 28, 2022, INCLUSIVE.
|
CLASS ACTION ALERT: THE LAW OFFICES OF VINCENT WONG REMIND Y-MABS INVESTORS OF A LEAD PLAINTIFF DEADLINE OF MARCH 20, 2023
|
YMAB
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2023-03-11 07:00:00
| null |
NEW YORK , MARCH 11, 2023 /PRNEWSWIRE/ -- FARUQI & FARUQI, LLP, A LEADING NATIONAL SECURITIES LAW FIRM, IS INVESTIGATING POTENTIAL CLAIMS AGAINST Y-MABS THERAPEUTICS, INC. ("Y-MABS" OR THE "COMPANY") (NASDAQ: YMAB) AND REMINDS INVESTORS OF THE MARCH 20, 2023 DEADLINE TO SEEK THE ROLE OF LEAD PLAINTIFF IN A FEDERAL SECURITIES CLASS ACTION THAT HAS BEEN FILED AGAINST THE COMPANY. IF YOU SUFFERED LOSSES EXCEEDING $100,000 INVESTING IN Y-MABS STOCK OR OPTIONS BETWEEN OCTOBER 6, 2020 AND OCTOBER 28, 2022 AND WOULD LIKE TO DISCUSS YOUR LEGAL RIGHTS, CALL FARUQI & FARUQI PARTNER JOSH WILSON DIRECTLY AT 877-247-4292 OR 212-983-9330 (EXT.
|
Y-MABS SHAREHOLDER ACTION REMINDER: SECURITIES LITIGATION PARTNER JAMES (JOSH) WILSON ENCOURAGES INVESTORS WHO SUFFERED LOSSES EXCEEDING $100,000 IN Y-MABS TO CONTACT HIM DIRECTLY TO DISCUSS THEIR OPTIONS
|
YMAB
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2023-03-10 05:45:00
| null |
NEW YORK , MARCH 10, 2023 /PRNEWSWIRE/ -- JAKUBOWITZ LAW ANNOUNCES THAT A SECURITIES FRAUD CLASS ACTION LAWSUIT HAS COMMENCED ON BEHALF OF SHAREHOLDERS OF Y-MABS THERAPEUTICS, INC. (NASDAQ: YMAB). TO RECEIVE UPDATES ON THE LAWSUIT, FILL OUT THE FORM: HTTPS://CLAIMYOURLOSS.COM/SECURITIES/Y-MABS-THERAPEUTICS-INC-LOSS-SUBMISSION-FORM/?ID=37153&FROM=4 THIS LAWSUIT IS ON BEHALF OF PERSONS OR ENTITIES WHO PURCHASED SHARES OF Y-MABS THERAPEUTICS, INC. COMMON STOCK ON THE OPEN MARKET OR PURSUANT TO REGISTRATION STATEMENTS FILED WITH THE U.S. SECURITIES AND EXCHANGE COMMISSION DURING THE PERIOD OCTOBER 6, 2020 THROUGH OCTOBER 28, 2022, INCLUSIVE.
|
YMAB SHAREHOLDER ALERT: JAKUBOWITZ LAW REMINDS Y-MABS SHAREHOLDERS OF A LEAD PLAINTIFF DEADLINE OF MARCH 20, 2023
|
YMAB
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2023-03-09 09:00:00
| null |
LOS ANGELES , MARCH 9, 2023 /PRNEWSWIRE/ -- THE LAW OFFICES OF FRANK R. CRUZ ANNOUNCES THAT INVESTORS WITH SUBSTANTIAL LOSSES HAVE OPPORTUNITY TO LEAD THE SECURITIES FRAUD CLASS ACTION LAWSUIT AGAINST Y-MABS THERAPEUTICS, INC. ("Y-MABS" OR THE "COMPANY") (NASDAQ: YMAB).
|
YMAB INVESTORS HAVE OPPORTUNITY TO LEAD Y-MABS THERAPEUTICS, INC. SECURITIES FRAUD LAWSUIT
|
YMAB
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2023-03-09 05:45:00
| null |
NEW YORK , MARCH 9, 2023 /PRNEWSWIRE/ -- LEVI & KORSINSKY, LLP NOTIFIES INVESTORS IN Y-MABS THERAPEUTICS, INC. ("Y-MABS" OR THE "COMPANY") (NASDAQ: YMAB) OF A CLASS ACTION SECURITIES LAWSUIT. CLASS DEFINITION: THE LAWSUIT SEEKS TO RECOVER LOSSES ON BEHALF OF Y-MABS INVESTORS WHO WERE ADVERSELY AFFECTED BY ALLEGED SECURITIES FRAUD.
|
YMAB LAWSUIT ALERT: LEVI & KORSINSKY NOTIFIES Y-MABS THERAPEUTICS, INC. INVESTORS OF A CLASS ACTION LAWSUIT AND UPCOMING DEADLINE
|
YMAB
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2023-03-08 21:15:00
| null |
NEW YORK , MARCH 8, 2023 /PRNEWSWIRE/ -- WHY: ROSEN LAW FIRM, A GLOBAL INVESTOR RIGHTS LAW FIRM, REMINDS PURCHASERS OF THE SECURITIES OF Y-MABS THERAPEUTICS, INC. (NASDAQ: YMAB) BETWEEN OCTOBER 6, 2020 AND OCTOBER 28, 2022, BOTH DATES INCLUSIVE (THE "CLASS PERIOD"), OF THE IMPORTANT MARCH 20, 2023 LEAD PLAINTIFF DEADLINE. SO WHAT: IF YOU PURCHASED Y-MABS SECURITIES YOU MAY BE ENTITLED TO COMPENSATION WITHOUT PAYMENT OF ANY OUT OF POCKET FEES OR COSTS THROUGH A CONTINGENCY FEE ARRANGEMENT.
|
GLOBALLY RECOGNIZED ROSEN LAW FIRM ENCOURAGES Y-MABS THERAPEUTICS, INC. INVESTORS TO SECURE COUNSEL BEFORE IMPORTANT DEADLINE IN SECURITIES CLASS ACTION - YMAB
|
YMAB
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2023-03-08 05:45:00
| null |
NEW YORK , MARCH 8, 2023 /PRNEWSWIRE/ -- THE GROSS LAW FIRM ISSUES THE FOLLOWING NOTICE TO SHAREHOLDERS OF Y-MABS THERAPEUTICS, INC.. SHAREHOLDERS WHO PURCHASED SHARES OF YMAB DURING THE CLASS PERIOD LISTED ARE ENCOURAGED TO CONTACT THE FIRM REGARDING POSSIBLE LEAD PLAINTIFF APPOINTMENT.
|
SHAREHOLDER ALERT: THE GROSS LAW FIRM NOTIFIES SHAREHOLDERS OF Y-MABS THERAPEUTICS, INC. OF A CLASS ACTION LAWSUIT AND A LEAD PLAINTIFF DEADLINE OF MARCH 20, 2023 - (NASDAQ: YMAB)
|
YMAB
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2023-03-08 01:45:00
| null |
DID YOU LOSE MONEY ON INVESTMENTS IN Y-MABS THERAPEUTICS? IF SO, PLEASE VISIT Y-MABS THERAPEUTICS, INC. SHAREHOLDER CLASS ACTION LAWSUIT OR CONTACT PETER ALLOCCO AT (212) 951-2030 OR PALLOCCO@BERNLIEB.COM TO DISCUSS YOUR RIGHTS.
|
Y-MABS THERAPEUTICS, INC. (NASDAQ: YMAB) SHAREHOLDER CLASS ACTION ALERT: BERNSTEIN LIEBHARD LLP REMINDS INVESTORS OF THE DEADLINE TO FILE A LEAD PLAINTIFF MOTION IN A SECURITIES CLASS ACTION LAWSUIT AGAINST Y-MABS THERAPEUTICS, INC. (NASDAQ: YMAB)
|
YMAB
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2023-03-07 05:45:00
| null |
NEW YORK , MARCH 7, 2023 /PRNEWSWIRE/ -- THE KLEIN LAW FIRM ANNOUNCES THAT A CLASS ACTION COMPLAINT HAS BEEN FILED ON BEHALF OF SHAREHOLDERS OF Y-MABS THERAPEUTICS, INC. (NASDAQ: YMAB) ALLEGING THAT THE COMPANY VIOLATED FEDERAL SECURITIES LAWS. THIS LAWSUIT IS ON BEHALF OF PERSONS OR ENTITIES WHO PURCHASED SHARES OF Y-MABS THERAPEUTICS, INC. COMMON STOCK ON THE OPEN MARKET OR PURSUANT TO REGISTRATION STATEMENTS FILED WITH THE U.S. SECURITIES AND EXCHANGE COMMISSION DURING THE PERIOD OCTOBER 6, 2020 THROUGH OCTOBER 28, 2022, INCLUSIVE.LEAD PLAINTIFF DEADLINE: MARCH 20, 2023 NO OBLIGATION OR COST TO YOU.
|
YMAB ALERT: THE KLEIN LAW FIRM ANNOUNCES A LEAD PLAINTIFF DEADLINE OF MARCH 20, 2023 IN THE CLASS ACTION FILED ON BEHALF OF Y-MABS THERAPEUTICS, INC. SHAREHOLDERS
|
YMAB
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2023-03-04 07:00:00
| null |
NEW YORK , MARCH 4, 2023 /PRNEWSWIRE/ -- FARUQI & FARUQI, LLP, A LEADING NATIONAL SECURITIES LAW FIRM, IS INVESTIGATING POTENTIAL CLAIMS AGAINST Y-MABS THERAPEUTICS, INC. ("Y-MABS" OR THE "COMPANY") (NASDAQ: YMAB) AND REMINDS INVESTORS OF THE MARCH 20, 2023 DEADLINE TO SEEK THE ROLE OF LEAD PLAINTIFF IN A FEDERAL SECURITIES CLASS ACTION THAT HAS BEEN FILED AGAINST THE COMPANY. IF YOU SUFFERED LOSSES EXCEEDING $100,000 INVESTING IN Y-MABS STOCK OR OPTIONS BETWEEN OCTOBER 6, 2020 AND OCTOBER 28, 2022 AND WOULD LIKE TO DISCUSS YOUR LEGAL RIGHTS, CALL FARUQI & FARUQI PARTNER JOSH WILSON DIRECTLY AT 877-247-4292 OR 212-983-9330 (EXT.
|
Y-MABS SHAREHOLDER ACTION REMINDER: SECURITIES LITIGATION PARTNER JAMES (JOSH) WILSON ENCOURAGES INVESTORS WHO SUFFERED LOSSES EXCEEDING $100,000 IN Y-MABS TO CONTACT HIM DIRECTLY TO DISCUSS THEIR OPTIONS
|
YMAB
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2023-03-03 22:25:00
| null |
NEW YORK , MARCH 3, 2023 /PRNEWSWIRE/ -- POMERANTZ LLP IS INVESTIGATING CLAIMS ON BEHALF OF INVESTORS OF Y-MABS THERAPEUTICS, INC. ("Y-MABS" OR THE "COMPANY") (NASDAQ: YMAB). SUCH INVESTORS ARE ADVISED TO CONTACT ROBERT S.
|
SHAREHOLDER ALERT: POMERANTZ LAW FIRM INVESTIGATES CLAIMS ON BEHALF OF INVESTORS OF Y-MABS THERAPEUTICS, INC. - YMAB
|
YMAB
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2023-03-03 13:00:00
| null |
LOS ANGELES , MARCH 3, 2023 /PRNEWSWIRE/ -- GLANCY PRONGAY & MURRAY LLP ("GPM") ANNOUNCES THAT INVESTORS WITH SUBSTANTIAL LOSSES HAVE OPPORTUNITY TO LEAD THE SECURITIES FRAUD CLASS ACTION LAWSUIT AGAINST Y-MABS THERAPEUTICS, INC. ("Y-MABS" OR THE "COMPANY") (NASDAQ: YMAB). CLASS PERIOD: OCTOBER 6, 2020 – OCTOBER 28, 2022 LEAD PLAINTIFF DEADLINE: MARCH 20, 2023 IF YOU WISH TO SERVE AS LEAD PLAINTIFF OF THE Y-MABS LAWSUIT, YOU CAN SUBMIT YOUR CONTACT INFORMATION AT WWW.GLANCYLAW.COM/CASES/Y-MABS-THERAPEUTICS-INC/.
|
YMAB INVESTORS HAVE OPPORTUNITY TO LEAD Y-MABS THERAPEUTICS, INC. SECURITIES FRAUD LAWSUIT
|
YMAB
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2023-03-03 05:45:00
| null |
NEW YORK , MARCH 3, 2023 /PRNEWSWIRE/ -- JAKUBOWITZ LAW ANNOUNCES THAT A SECURITIES FRAUD CLASS ACTION LAWSUIT HAS COMMENCED ON BEHALF OF SHAREHOLDERS OF Y-MABS THERAPEUTICS, INC. (NASDAQ: YMAB). TO RECEIVE UPDATES ON THE LAWSUIT, FILL OUT THE FORM: HTTPS://CLAIMYOURLOSS.COM/SECURITIES/Y-MABS-THERAPEUTICS-INC-LOSS-SUBMISSION-FORM/?ID=36966&FROM=4 THIS LAWSUIT IS ON BEHALF OF PERSONS OR ENTITIES WHO PURCHASED SHARES OF Y-MABS THERAPEUTICS, INC. COMMON STOCK ON THE OPEN MARKET OR PURSUANT TO REGISTRATION STATEMENTS FILED WITH THE U.S. SECURITIES AND EXCHANGE COMMISSION DURING THE PERIOD OCTOBER 6, 2020 THROUGH OCTOBER 28, 2022, INCLUSIVE.
|
YMAB SHAREHOLDER ALERT: JAKUBOWITZ LAW REMINDS Y-MABS SHAREHOLDERS OF A LEAD PLAINTIFF DEADLINE OF MARCH 20, 2023
|
YMAB
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2023-03-02 05:45:00
| null |
NEW YORK , MARCH 2, 2023 /PRNEWSWIRE/ -- LEVI & KORSINSKY, LLP NOTIFIES INVESTORS IN Y-MABS THERAPEUTICS, INC. ("Y-MABS" OR THE "COMPANY") (NASDAQ: YMAB) OF A CLASS ACTION SECURITIES LAWSUIT. CLASS DEFINITION: THE LAWSUIT SEEKS TO RECOVER LOSSES ON BEHALF OF Y-MABS INVESTORS WHO WERE ADVERSELY AFFECTED BY ALLEGED SECURITIES FRAUD.
|
YMAB LAWSUIT ALERT: LEVI & KORSINSKY NOTIFIES Y-MABS THERAPEUTICS, INC. INVESTORS OF A CLASS ACTION LAWSUIT AND UPCOMING DEADLINE
|
YMAB
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2023-03-01 18:00:00
| null |
NEW YORK , MARCH 1, 2023 /PRNEWSWIRE/ -- WHY: ROSEN LAW FIRM, A GLOBAL INVESTOR RIGHTS LAW FIRM, REMINDS PURCHASERS OF THE SECURITIES OF Y-MABS THERAPEUTICS, INC. (NASDAQ: YMAB) BETWEEN OCTOBER 6, 2020 AND OCTOBER 28, 2022, BOTH DATES INCLUSIVE (THE "CLASS PERIOD"), OF THE IMPORTANT MARCH 20, 2023 LEAD PLAINTIFF DEADLINE. SO WHAT: IF YOU PURCHASED Y-MABS SECURITIES YOU MAY BE ENTITLED TO COMPENSATION WITHOUT PAYMENT OF ANY OUT OF POCKET FEES OR COSTS THROUGH A CONTINGENCY FEE ARRANGEMENT.
|
ROSEN, A LONGSTANDING AND TRUSTED FIRM, ENCOURAGES Y-MABS THERAPEUTICS, INC. INVESTORS TO SECURE COUNSEL BEFORE IMPORTANT DEADLINE IN SECURITIES CLASS ACTION - YMAB
|
YMAB
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2023-03-01 05:45:00
| null |
NEW YORK , MARCH 1, 2023 /PRNEWSWIRE/ -- THE GROSS LAW FIRM ISSUES THE FOLLOWING NOTICE TO SHAREHOLDERS OF Y-MABS THERAPEUTICS, INC.. SHAREHOLDERS WHO PURCHASED SHARES OF YMAB DURING THE CLASS PERIOD LISTED ARE ENCOURAGED TO CONTACT THE FIRM REGARDING POSSIBLE LEAD PLAINTIFF APPOINTMENT.
|
SHAREHOLDER ALERT: THE GROSS LAW FIRM NOTIFIES SHAREHOLDERS OF Y-MABS THERAPEUTICS, INC. OF A CLASS ACTION LAWSUIT AND A LEAD PLAINTIFF DEADLINE OF MARCH 20, 2023 - (NASDAQ: YMAB)
|
YMAB
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2023-02-27 16:30:00
| null |
DID YOU LOSE MONEY ON INVESTMENTS IN Y-MABS THERAPEUTICS? IF SO, PLEASE VISIT Y-MABS THERAPEUTICS, INC. SHAREHOLDER CLASS ACTION LAWSUIT OR CONTACT PETER ALLOCCO AT (212) 951-2030 OR PALLOCCO@BERNLIEB.COM TO DISCUSS YOUR RIGHTS.
|
Y-MABS THERAPEUTICS, INC. (NASDAQ: YMAB) SHAREHOLDER CLASS ACTION ALERT: BERNSTEIN LIEBHARD LLP REMINDS INVESTORS OF THE DEADLINE TO FILE A LEAD PLAINTIFF MOTION IN A SECURITIES CLASS ACTION LAWSUIT AGAINST Y-MABS THERAPEUTICS, INC. (NASDAQ: YMAB)
|
YMAB
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2023-02-27 05:45:00
| null |
NEW YORK , FEB. 27, 2023 /PRNEWSWIRE/ -- ATTENTION Y-MABS THERAPEUTICS, INC. ("Y-MABS") (NASDAQ: YMAB) SHAREHOLDERS: THE LAW OFFICES OF VINCENT WONG ANNOUNCE THAT A CLASS ACTION LAWSUIT HAS COMMENCED ON BEHALF OF INVESTORS. THIS LAWSUIT IS ON BEHALF OF PERSONS OR ENTITIES WHO PURCHASED SHARES OF Y-MABS THERAPEUTICS, INC. COMMON STOCK ON THE OPEN MARKET OR PURSUANT TO REGISTRATION STATEMENTS FILED WITH THE U.S. SECURITIES AND EXCHANGE COMMISSION DURING THE PERIOD OCTOBER 6, 2020 THROUGH OCTOBER 28, 2022, INCLUSIVE.
|
CLASS ACTION ALERT: THE LAW OFFICES OF VINCENT WONG REMIND Y-MABS INVESTORS OF A LEAD PLAINTIFF DEADLINE OF MARCH 20, 2023
|
YMAB
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2023-02-25 07:00:00
| null |
NEW YORK , FEB. 25, 2023 /PRNEWSWIRE/ -- FARUQI & FARUQI, LLP, A LEADING NATIONAL SECURITIES LAW FIRM, IS INVESTIGATING POTENTIAL CLAIMS AGAINST Y-MABS THERAPEUTICS, INC. ("Y-MABS" OR THE "COMPANY") (NASDAQ: YMAB) AND REMINDS INVESTORS OF THE MARCH 20, 2023 DEADLINE TO SEEK THE ROLE OF LEAD PLAINTIFF IN A FEDERAL SECURITIES CLASS ACTION THAT HAS BEEN FILED AGAINST THE COMPANY. IF YOU SUFFERED LOSSES EXCEEDING $100,000 INVESTING IN Y-MABS STOCK OR OPTIONS BETWEEN OCTOBER 6, 2020 AND OCTOBER 28, 2022 AND WOULD LIKE TO DISCUSS YOUR LEGAL RIGHTS, CALL FARUQI & FARUQI PARTNER JOSH WILSON DIRECTLY AT 877-247-4292 OR 212-983-9330 (EXT.
|
Y-MABS INVESTOR ALERT: SECURITIES LITIGATION PARTNER JAMES (JOSH) WILSON ENCOURAGES INVESTORS WHO SUFFERED LOSSES EXCEEDING $100,000 IN Y-MABS TO CONTACT HIM DIRECTLY TO DISCUSS THEIR OPTIONS
|
YMAB
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2023-02-24 13:00:00
| null |
BENSALEM, PA. , FEB. 24, 2023 /PRNEWSWIRE/ -- LAW OFFICES OF HOWARD G.
|
YMAB INVESTORS HAVE OPPORTUNITY TO LEAD Y-MABS THERAPEUTICS, INC. SECURITIES FRAUD LAWSUIT
|
YMAB
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2023-02-23 17:49:00
| null |
NEW YORK , FEB. 23, 2023 /PRNEWSWIRE/ -- WHY: ROSEN LAW FIRM, A GLOBAL INVESTOR RIGHTS LAW FIRM, REMINDS PURCHASERS OF THE SECURITIES OF Y-MABS THERAPEUTICS, INC. (NASDAQ: YMAB) BETWEEN OCTOBER 6, 2020 AND OCTOBER 28, 2022, BOTH DATES INCLUSIVE (THE "CLASS PERIOD"), OF THE IMPORTANT MARCH 20, 2023 LEAD PLAINTIFF DEADLINE. SO WHAT: IF YOU PURCHASED Y-MABS SECURITIES YOU MAY BE ENTITLED TO COMPENSATION WITHOUT PAYMENT OF ANY OUT OF POCKET FEES OR COSTS THROUGH A CONTINGENCY FEE ARRANGEMENT.
|
ROSEN, A TOP RANKED LAW FIRM, ENCOURAGES Y-MABS THERAPEUTICS, INC. INVESTORS TO SECURE COUNSEL BEFORE IMPORTANT DEADLINE IN SECURITIES CLASS ACTION - YMAB
|
YMAB
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2023-02-23 05:45:00
| null |
NEW YORK , FEB. 23, 2023 /PRNEWSWIRE/ -- LEVI & KORSINSKY, LLP NOTIFIES INVESTORS IN Y-MABS THERAPEUTICS, INC. ("Y-MABS" OR THE "COMPANY") (NASDAQ: YMAB) OF A CLASS ACTION SECURITIES LAWSUIT. CLASS DEFINITION: THE LAWSUIT SEEKS TO RECOVER LOSSES ON BEHALF OF Y-MABS INVESTORS WHO WERE ADVERSELY AFFECTED BY ALLEGED SECURITIES FRAUD.
|
YMAB LAWSUIT ALERT: LEVI & KORSINSKY NOTIFIES Y-MABS THERAPEUTICS, INC. INVESTORS OF A CLASS ACTION LAWSUIT AND UPCOMING DEADLINE
|
YMAB
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2023-02-22 21:30:00
| null |
NEW YORK , FEB. 22, 2023 /PRNEWSWIRE/ -- POMERANTZ LLP IS INVESTIGATING CLAIMS ON BEHALF OF INVESTORS OF Y-MABS THERAPEUTICS, INC. ("Y-MABS" OR THE "COMPANY") (NASDAQ: YMAB). SUCH INVESTORS ARE ADVISED TO CONTACT ROBERT S.
|
SHAREHOLDER ALERT: POMERANTZ LAW FIRM INVESTIGATES CLAIMS ON BEHALF OF INVESTORS OF Y-MABS THERAPEUTICS, INC. - YMAB
|
YMAB
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2023-02-22 20:17:00
| null |
NEW YORK , FEB. 22, 2023 /PRNEWSWIRE/ -- POMERANTZ LLP IS INVESTIGATING CLAIMS ON BEHALF OF INVESTORS OF Y-MABS THERAPEUTICS, INC. ("Y-MABS" OR THE "COMPANY") (NASDAQ: YMAB). SUCH INVESTORS ARE ADVISED TO CONTACT ROBERT S.
|
SHAREHOLDER ALERT: POMERANTZ LAW FIRM INVESTIGATES CLAIMS ON BEHALF OF INVESTORS OF Y-MABS THERAPEUTICS, INC. - YMAB
|
YMAB
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2023-02-22 01:45:00
| null |
DID YOU LOSE MONEY ON INVESTMENTS IN Y-MABS THERAPEUTICS? IF SO, PLEASE VISIT Y-MABS THERAPEUTICS, INC. SHAREHOLDER CLASS ACTION LAWSUIT OR CONTACT PETER ALLOCCO AT (212) 951-2030 OR PALLOCCO@BERNLIEB.COM TO DISCUSS YOUR RIGHTS.
|
Y-MABS THERAPEUTICS, INC. (NASDAQ: YMAB) SHAREHOLDER CLASS ACTION ALERT: BERNSTEIN LIEBHARD LLP REMINDS INVESTORS OF THE DEADLINE TO FILE A LEAD PLAINTIFF MOTION IN A SECURITIES CLASS ACTION LAWSUIT AGAINST Y-MABS THERAPEUTICS, INC. (NASDAQ: YMAB)
|
YMAB
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2023-02-21 23:44:00
| null |
NEW ORLEANS , FEB. 21, 2023 /PRNEWSWIRE/ -- KAHN SWICK & FOTI, LLC ("KSF") AND KSF PARTNER, FORMER ATTORNEY GENERAL OF LOUISIANA, CHARLES C. FOTI, JR., REMIND INVESTORS THAT THEY HAVE UNTIL MARCH 20, 2023 TO FILE LEAD PLAINTIFF APPLICATIONS IN A SECURITIES CLASS ACTION LAWSUIT AGAINST Y-MABS THERAPEUTICS, INC. (NASDAQGS: YMAB), IF THEY PURCHASED THE COMPANY'S SECURITIES BETWEEN OCTOBER 6, 2020 AND OCTOBER 28, 2022, INCLUSIVE (THE "CLASS PERIOD").
|
Y-MABS THERAPEUTICS SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 OF LEAD PLAINTIFF DEADLINE IN CLASS ACTION LAWSUIT AGAINST Y-MABS THERAPEUTICS, INC. - YMAB
|
YMAB
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2023-02-21 12:00:00
| null |
LOS ANGELES , FEB. 21, 2023 /PRNEWSWIRE/ -- THE LAW OFFICES OF FRANK R. CRUZ ANNOUNCES THAT INVESTORS WITH SUBSTANTIAL LOSSES HAVE OPPORTUNITY TO LEAD THE SECURITIES FRAUD CLASS ACTION LAWSUIT AGAINST Y-MABS THERAPEUTICS, INC. ("Y-MABS" OR THE "COMPANY") (NASDAQ: YMAB).
|
YMAB INVESTORS HAVE OPPORTUNITY TO LEAD Y-MABS THERAPEUTICS, INC. SECURITIES FRAUD LAWSUIT
|
YMAB
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2023-02-21 05:45:00
| null |
NEW YORK , FEB. 21, 2023 /PRNEWSWIRE/ -- THE KLEIN LAW FIRM ANNOUNCES THAT A CLASS ACTION COMPLAINT HAS BEEN FILED ON BEHALF OF SHAREHOLDERS OF Y-MABS THERAPEUTICS, INC. (NASDAQ: YMAB) ALLEGING THAT THE COMPANY VIOLATED FEDERAL SECURITIES LAWS. THIS LAWSUIT IS ON BEHALF OF PERSONS OR ENTITIES WHO PURCHASED SHARES OF Y-MABS THERAPEUTICS, INC. COMMON STOCK ON THE OPEN MARKET OR PURSUANT TO REGISTRATION STATEMENTS FILED WITH THE U.S. SECURITIES AND EXCHANGE COMMISSION DURING THE PERIOD OCTOBER 6, 2020 THROUGH OCTOBER 28, 2022, INCLUSIVE.LEAD PLAINTIFF DEADLINE: MARCH 20, 2023 NO OBLIGATION OR COST TO YOU.
|
YMAB ALERT: THE KLEIN LAW FIRM ANNOUNCES A LEAD PLAINTIFF DEADLINE OF MARCH 20, 2023 IN THE CLASS ACTION FILED ON BEHALF OF Y-MABS THERAPEUTICS, INC. SHAREHOLDERS
|
YMAB
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2023-02-18 11:00:00
| null |
NEW YORK , FEB. 18, 2023 /PRNEWSWIRE/ -- FARUQI & FARUQI, LLP, A LEADING NATIONAL SECURITIES LAW FIRM, IS INVESTIGATING POTENTIAL CLAIMS AGAINST Y-MABS THERAPEUTICS, INC. ("Y-MABS" OR THE "COMPANY") (NASDAQ: YMAB) AND REMINDS INVESTORS OF THE MARCH 20, 2023 DEADLINE TO SEEK THE ROLE OF LEAD PLAINTIFF IN A FEDERAL SECURITIES CLASS ACTION THAT HAS BEEN FILED AGAINST THE COMPANY. IF YOU SUFFERED LOSSES EXCEEDING $100,000 INVESTING IN Y-MABS STOCK OR OPTIONS BETWEEN OCTOBER 6, 2020 AND OCTOBER 28, 2022 AND WOULD LIKE TO DISCUSS YOUR LEGAL RIGHTS, CALL FARUQI & FARUQI PARTNER JOSH WILSON DIRECTLY AT 877-247-4292 OR 212-983-9330 (EXT.
|
Y-MABS INVESTOR ALERT: SECURITIES LITIGATION PARTNER JAMES (JOSH) WILSON ENCOURAGES INVESTORS WHO SUFFERED LOSSES EXCEEDING $100,000 IN Y-MABS TO CONTACT HIM DIRECTLY TO DISCUSS THEIR OPTIONS
|
YMAB
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2023-02-17 20:01:00
| null |
SECURITIES LITIGATION PARTNER JAMES (JOSH) WILSON ENCOURAGES INVESTORS WHO SUFFERED LOSSES EXCEEDING $100,000 IN Y-MABS TO CONTACT HIM DIRECTLY TO DISCUSS THEIR OPTIONSNEW YORK, NEW YORK--(NEWSFILE CORP. - FEBRUARY 17, 2023) - FARUQI & FARUQI, LLP, A LEADING NATIONAL SECURITIES LAW FIRM, IS INVESTIGATING POTENTIAL CLAIMS AGAINST Y-MABS THERAPEUTICS, INC. ("Y-MABS" OR THE "COMPANY") (NASDAQ: YMAB) AND REMINDS INVESTORS OF THE MARCH 20, 2023 DEADLINE TO SEEK THE ROLE OF LEAD PLAINTIFF IN A FEDERAL SECURITIES CLASS ACTION THAT HAS BEEN FILED AGAINST THE COMPANY.
|
Y-MABS SHAREHOLDER ACTION REMINDER
|
YMAB
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2023-02-17 13:00:00
| null |
LOS ANGELES , FEB. 17, 2023 /PRNEWSWIRE/ -- GLANCY PRONGAY & MURRAY LLP ("GPM") ANNOUNCES THAT INVESTORS WITH SUBSTANTIAL LOSSES HAVE OPPORTUNITY TO LEAD THE SECURITIES FRAUD CLASS ACTION LAWSUIT AGAINST Y-MABS THERAPEUTICS, INC. ("Y-MABS" OR THE "COMPANY") (NASDAQ: YMAB). CLASS PERIOD: OCTOBER 6, 2020 – OCTOBER 28, 2022 LEAD PLAINTIFF DEADLINE: MARCH 20, 2023 IF YOU WISH TO SERVE AS LEAD PLAINTIFF OF THE Y-MABS LAWSUIT, YOU CAN SUBMIT YOUR CONTACT INFORMATION AT WWW.GLANCYLAW.COM/CASES/Y-MABS-THERAPEUTICS-INC/.
|
YMAB INVESTORS HAVE OPPORTUNITY TO LEAD Y-MABS THERAPEUTICS, INC. SECURITIES FRAUD LAWSUIT
|
YMAB
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2023-02-17 11:23:00
| null |
NEW YORK, NEW YORK--(NEWSFILE CORP. - FEBRUARY 17, 2023) - WHY: ROSEN LAW FIRM, A GLOBAL INVESTOR RIGHTS LAW FIRM, REMINDS PURCHASERS OF THE SECURITIES OF Y-MABS THERAPEUTICS, INC. (NASDAQ: YMAB) BETWEEN OCTOBER 6, 2020 AND OCTOBER 28, 2022, BOTH DATES INCLUSIVE (THE "CLASS PERIOD"), OF THE IMPORTANT MARCH 20, 2023 LEAD PLAINTIFF DEADLINE.
|
NATIONALLY RANKED ROSEN LAW FIRM ENCOURAGES Y-MABS THERAPEUTICS, INC. INVESTORS WITH LOSSES TO SECURE COUNSEL BEFORE IMPORTANT DEADLINE IN SECURITIES CLASS ACTION - YMAB
|
YMAB
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2023-02-16 16:33:00
| null |
NEW YORK , FEB. 16, 2023 /PRNEWSWIRE/ -- WHY: ROSEN LAW FIRM, A GLOBAL INVESTOR RIGHTS LAW FIRM, REMINDS PURCHASERS OF THE SECURITIES OF Y-MABS THERAPEUTICS, INC. (NASDAQ: YMAB) BETWEEN OCTOBER 6, 2020 AND OCTOBER 28, 2022, BOTH DATES INCLUSIVE (THE "CLASS PERIOD"), OF THE IMPORTANT MARCH 20, 2023 LEAD PLAINTIFF DEADLINE. SO WHAT: IF YOU PURCHASED Y-MABS SECURITIES YOU MAY BE ENTITLED TO COMPENSATION WITHOUT PAYMENT OF ANY OUT OF POCKET FEES OR COSTS THROUGH A CONTINGENCY FEE ARRANGEMENT.
|
YMAB LOSS ALERT: ROSEN, GLOBALLY RECOGNIZED INVESTOR COUNSEL, ENCOURAGES Y-MABS THERAPEUTICS, INC. INVESTORS TO SECURE COUNSEL BEFORE IMPORTANT DEADLINE IN SECURITIES CLASS ACTION - YMAB
|
YMAB
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2023-02-16 14:30:00
| null |
NEW YORK, NEW YORK--(NEWSFILE CORP. - FEBRUARY 16, 2023) - LEVI & KORSINSKY, LLP NOTIFIES INVESTORS IN Y-MABS THERAPEUTICS, INC. ("Y-MABS" OR THE "COMPANY") (NASDAQ: YMAB) OF A CLASS ACTION SECURITIES LAWSUIT.THE LAWSUIT ON BEHALF OF Y-MABS INVESTORS HAS BEEN COMMENCED IN THE THE UNITED STATES DISTRICT COURT FOR THE SOUTHERN DISTRICT OF NEW YORK. THIS LAWSUIT IS ON BEHALF OF PERSONS OR ENTITIES WHO PURCHASED SHARES OF Y-MABS THERAPEUTICS, INC.
|
Y-MABS CLASS ACTION: LEVI & KORSINSKY REMINDS Y-MABS THERAPEUTICS, INC. INVESTORS OF THE PENDING CLASS ACTION LAWSUIT WITH A LEAD PLAINTIFF DEADLINE OF MARCH 20, 2023 - YMAB
|
YMAB
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.